Neuronal	B-protein
(	I-protein
type	I-protein
I	I-protein
)	I-protein
nitric	I-protein
oxide	I-protein
synthase	I-protein
regulates	O
nuclear	B-protein
factor	I-protein
kappaB	I-protein
activity	O
and	O
immunologic	B-protein
(	I-protein
type	I-protein
II	I-protein
)	I-protein
nitric	I-protein
oxide	I-protein
synthase	I-protein
expression	O
.	O

Nitric	O
oxide	O
subserves	O
diverse	O
physiologic	O
roles	O
in	O
the	O
nervous	O
system	O
.	O

NO	O
is	O
produced	O
from	O
at	O
least	O
three	O
different	O
NO	B-protein
synthase	I-protein
(	I-protein
NOS	I-protein
)	I-protein
isoforms	I-protein
:	O
neuronal	B-protein
NOS	I-protein
(	O
nNOS	B-protein
)	O
,	O
endothelial	B-protein
NOS	I-protein
,	O
and	O
immunologic	B-protein
NOS	I-protein
(	O
iNOS	B-protein
)	O
.	O

We	O
show	O
that	O
nNOS	B-protein
is	O
the	O
predominant	O
isoform	O
constitutively	O
expressed	O
in	O
glia	B-cell_type
.	O

NO	O
derived	O
from	O
nNOS	B-protein
in	O
glia	B-cell_type
inhibits	O
the	O
transcription	B-protein
factor	I-protein
nuclear	B-protein
factor	I-protein
kappaB	I-protein
(	O
NF	B-protein
kappaB	I-protein
)	O
as	O
NOS	O
inhibitors	O
enhance	O
basal	O
NF	B-protein
kappaB	I-protein
activation	O
.	O

Pyrrolidine	O
dithiocarbamate	O
(	O
PDTC	O
)	O
is	O
an	O
inhibitor	O
of	O
NF	B-protein
kappaB	I-protein
in	O
most	O
cells	O
;	O
however	O
,	O
we	O
show	O
that	O
PDTC	O
is	O
also	O
a	O
potent	O
scavenger	O
of	O
NO	O
through	O
formation	O
of	O
mononitrosyl	O
iron	O
complexes	O
with	O
PDTC	O
.	O

In	O
Jurkat	B-cell_line
cells	I-cell_line
,	O
a	O
human	O
T-cell	B-cell_line
lymphoma	I-cell_line
cell	I-cell_line
line	I-cell_line
,	O
tumor	B-protein
necrosis	I-protein
factor-alpha	I-protein
(	O
TNF-alpha	B-protein
)	O
induces	O
NF	B-protein
kappaB	I-protein
activation	O
that	O
is	O
inhibited	O
by	O
PDTC	O
.	O

Contrary	O
to	O
the	O
results	O
in	O
Jurkat	B-cell_line
cells	I-cell_line
,	O
PDTC	O
did	O
not	O
inhibit	O
tumor	B-protein
necrosis	I-protein
factor-alpha	I-protein
-induced	O
NF	B-protein
kappaB	I-protein
activation	O
in	O
astrocytes	B-cell_type
;	O
instead	O
PDTC	O
itself	O
induces	O
NF	B-protein
kappaB	I-protein
activation	O
in	O
astrocytes	B-cell_type
,	O
and	O
this	O
may	O
be	O
related	O
to	O
scavenging	O
of	O
endogenously	O
produced	O
NO	O
by	O
the	O
PDTC	O
iron	O
complex	O
.	O

In	O
astrocytes	B-cell_type
PDTC	O
also	O
dramatically	O
induces	O
the	O
NF	B-protein
kappaB-dependent	I-protein
enzyme	I-protein
,	O
iNOS	B-protein
,	O
supporting	O
the	O
physiologic	O
relevance	O
of	O
endogenous	O
NO	O
regulation	O
of	O
NF	B-protein
kappaB	I-protein
.	O

NF	B-protein
kappaB	I-protein
activation	O
in	O
glia	B-cell_type
from	O
mice	O
lacking	O
nNOS	B-protein
responds	O
more	O
rapidly	O
to	O
PDTC	O
compared	O
with	O
astrocytes	B-cell_type
from	O
wild-type	O
mice	O
.	O

Our	O
data	O
suggest	O
that	O
nNOS	B-protein
in	O
astrocytes	B-cell_type
regulates	O
NF	B-protein
kappaB	I-protein
activity	O
and	O
iNOS	B-protein
expression	O
,	O
and	O
indicate	O
a	O
novel	O
regulatory	O
role	O
for	O
nNOS	B-protein
in	O
tonically	O
suppressing	O
central	O
nervous	O
system	O
,	O
NF	B-DNA
kappaB-regulated	I-DNA
genes	I-DNA
.	O

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
Vol	NULL
.	NULL

94	NULL
,	NULL
pp	NULL
.	NULL

2676-2680	NULL
,	NULL
March	NULL
1997	NULL
Neurobiology	NULL
Neuronal	NULL
(	NULL
type	NULL
I	NULL
)	NULL
nitric	NULL
oxide	NULL
synthase	NULL
regulates	NULL
nuclear	NULL
factorKB	NULL
activity	NULL
and	NULL
immunologic	NULL
(	NULL
type	NULL
II	NULL
)	NULL
nitric	NULL
oxide	NULL
synthase	NULL
expression	NULL
TocasHI**	NULL
,	NULL
MasaYyUKI	NULL
SasakI*	NULL
#	NULL
,	NULL
Epurot	NULL
FrRonmaN*§	NULL
,	NULL
Ect	NULL
TaiRa	NULL
$	NULL
,	NULL
Rav	NULL
R.	NULL
Ratan*	NULL
#	NULL
``	NULL
,	NULL
TED	NULL
M.	NULL
Dawson*	NULL
?	NULL

#	NULL
,	NULL
AND	NULL
VALINA	NULL
L.	NULL
Dawson	NULL
*	NULL
#	NULL
ll	NULL
,	NULL
**	NULL
Departments	NULL
of	NULL
*Neurology	NULL
,	NULL
Neuroscience	NULL
,	NULL
and	NULL
``	NULL
Physiology	NULL
,	NULL
Johns	NULL
Hopkins	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
Baltimore	NULL
,	NULL
MD	NULL
21287	NULL
Communicated	NULL
by	NULL
Bernhard	NULL
Witkop	NULL
,	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
,	NULL
Bethesda	NULL
,	NULL
MD	NULL
,	NULL
January	NULL
2	NULL
,	NULL
1997	NULL
(	NULL
received	NULL
for	NULL
review	NULL
October	NULL
23	NULL
,	NULL
1996	NULL
)	NULL
ABSTRACT	NULL
Nitric	NULL
oxide	NULL
subserves	NULL
diverse	NULL
physiologic	NULL
roles	NULL
in	NULL
the	NULL
nervous	NULL
system	NULL
.	NULL

NO	NULL
is	NULL
produced	NULL
from	NULL
at	NULL
least	NULL
three	NULL
different	NULL
NO	NULL
synthase	NULL
(	NULL
NOS	NULL
)	NULL
isoforms	NULL
:	NULL
neuronal	NULL
NOS	NULL
(	NULL
nNOS	NULL
)	NULL
,	NULL
endothelial	NULL
NOS	NULL
,	NULL
and	NULL
immunologic	NULL
NOS	NULL
(	NULL
INOS	NULL
)	NULL
.	NULL

We	NULL
show	NULL
that	NULL
nNOS	NULL
is	NULL
the	NULL
predominant	NULL
isoform	NULL
constitutively	NULL
expressed	NULL
in	NULL
glia	NULL
.	NULL

NO	NULL
derived	NULL
from	NULL
nNOS	NULL
in	NULL
glia	NULL
inhibits	NULL
the	NULL
transcription	NULL
factor	NULL
nuclear	NULL
factor	NULL
«	NULL
B	NULL
(	NULL
NFB	NULL
)	NULL
as	NULL
NOS	NULL
inhibitors	NULL
enhance	NULL
basal	NULL
NFB	NULL
activation	NULL
.	NULL

Pyrrolidine	NULL
dithiocar-bamate	NULL
(	NULL
PDTC	NULL
)	NULL
is	NULL
an	NULL
inhibitor	NULL
of	NULL
NFB	NULL
in	NULL
most	NULL
cells	NULL
;	NULL
however	NULL
,	NULL
we	NULL
show	NULL
that	NULL
PDTC	NULL
is	NULL
also	NULL
a	NULL
potent	NULL
scavenger	NULL
of	NULL
NO	NULL
through	NULL
formation	NULL
of	NULL
mononitrosyl	NULL
iron	NULL
complexes	NULL
with	NULL
PDTC	NULL
.	NULL

In	NULL
Jurkat	NULL
cells	NULL
,	NULL
a	NULL
human	NULL
T-cell	NULL
lymphoma	NULL
cell	NULL
line	NULL
,	NULL
tumor	NULL
necrosis	NULL
factor-a	NULL
(	NULL
TNF-a	NULL
)	NULL
induces	NULL
NFB	NULL
activation	NULL
that	NULL
is	NULL
inhibited	NULL
by	NULL
PDTC	NULL
.	NULL

Contrary	NULL
to	NULL
the	NULL
results	NULL
in	NULL
Jurkat	NULL
cells	NULL
,	NULL
PDTC	NULL
did	NULL
not	NULL
inhibit	NULL
tumor	NULL
necrosis	NULL
factor-	NULL
&	NULL
-induced	NULL
NFB	NULL
activation	NULL
in	NULL
astrocytes	NULL
;	NULL
instead	NULL
PDTC	NULL
itself	NULL
induces	NULL
NFB	NULL
activation	NULL
in	NULL
astrocytes	NULL
,	NULL
and	NULL
this	NULL
may	NULL
be	NULL
related	NULL
to	NULL
scavenging	NULL
of	NULL
endogenously	NULL
produced	NULL
NO	NULL
by	NULL
the	NULL
PDTC	NULL
iron	NULL
complex	NULL
.	NULL

In	NULL
astrocytes	NULL
PDTC	NULL
also	NULL
dramatically	NULL
induces	NULL
the	NULL
NFKB-dependent	NULL
enzyme	NULL
,	NULL
iNOS	NULL
,	NULL
supporting	NULL
the	NULL
physiologic	NULL
relevance	NULL
of	NULL
endogenous	NULL
NO	NULL
regulation	NULL
of	NULL
NFB	NULL
.	NULL

NFB	NULL
activation	NULL
in	NULL
glia	NULL
from	NULL
mice	NULL
lacking	NULL
nNOS	NULL
responds	NULL
more	NULL
rapidly	NULL
to	NULL
PDTC	NULL
compared	NULL
with	NULL
astrocytes	NULL
from	NULL
wild-type	NULL
mice	NULL
.	NULL

Our	NULL
data	NULL
suggest	NULL
that	NULL
nNOS	NULL
in	NULL
astrocytes	NULL
regulates	NULL
NFB	NULL
activity	NULL
and	NULL
iNOS	NULL
expression	NULL
,	NULL
and	NULL
indicate	NULL
a	NULL
novel	NULL
regulatory	NULL
role	NULL
for	NULL
nNOS	NULL
in	NULL
tonically	NULL
suppressing	NULL
central	NULL
nervous	NULL
system	NULL
,	NULL
NFKB-regulated	NULL
genes	NULL
.	NULL

Nitric	NULL
oxide	NULL
is	NULL
a	NULL
potent	NULL
messenger	NULL
molecule	NULL
with	NULL
diverse	NULL
physiologic	NULL
activities	NULL
,	NULL
including	NULL
regulation	NULL
of	NULL
vascular	NULL
tone	NULL
,	NULL
neurotransmission	NULL
,	NULL
and	NULL
killing	NULL
of	NULL
microorganisms	NULL
and	NULL
tumor	NULL
cells	NULL
(	NULL
1-3	NULL
)	NULL
.	NULL

NO	NULL
is	NULL
produced	NULL
from	NULL
L-arginine	NULL
(	NULL
L-Arg	NULL
)	NULL
by	NULL
the	NULL
enzyme	NULL
NO	NULL
synthase	NULL
(	NULL
NOS	NULL
)	NULL
.	NULL

A	NULL
family	NULL
of	NULL
related	NULL
NOS	NULL
proteins	NULL
are	NULL
the	NULL
products	NULL
of	NULL
different	NULL
genes	NULL
and	NULL
include	NULL
neuronal	NULL
NOS	NULL
(	NULL
nNOS	NULL
,	NULL
type	NULL
1	NULL
)	NULL
,	NULL
immunologic	NULL
NOS	NULL
(	NULL
iNOS	NULL
,	NULL
type	NULL
2	NULL
)	NULL
,	NULL
and	NULL
endothelial	NULL
NOS	NULL
(	NULL
eNOS	NULL
,	NULL
type	NULL
3	NULL
)	NULL
(	NULL
3	NULL
)	NULL
.	NULL

nNOS	NULL
occurs	NULL
in	NULL
discreet	NULL
neuronal	NULL
populations	NULL
in	NULL
the	NULL
brain	NULL
and	NULL
also	NULL
is	NULL
localized	NULL
to	NULL
the	NULL
sarcoplasmic	NULL
reticulum	NULL
of	NULL
skeletal	NULL
muscle	NULL
(	NULL
4	NULL
)	NULL
.	NULL

eNOS	NULL
primarily	NULL
has	NULL
endothelial	NULL
cell	NULL
localizations	NULL
,	NULL
but	NULL
also	NULL
is	NULL
localized	NULL
to	NULL
a	NULL
variety	NULL
of	NULL
other	NULL
tissue	NULL
types	NULL
,	NULL
including	NULL
CA1	NULL
pyramidal	NULL
cells	NULL
of	NULL
the	NULL
hippocampus	NULL
(	NULL
5	NULL
)	NULL
.	NULL

Both	NULL
nNOS	NULL
and	NULL
eNOS	NULL
are	NULL
constitutively	NULL
expressed	NULL
and	NULL
are	NULL
calcium-calmodulin-dependent	NULL
enzymes	NULL
(	NULL
3	NULL
,	NULL
4	NULL
)	NULL
.	NULL

iNOS	NULL
is	NULL
expressed	NULL
in	NULL
response	NULL
to	NULL
cytokines	NULL
,	NULL
lipopolysac-charide	NULL
(	NULL
LPS	NULL
)	NULL
,	NULL
and	NULL
a	NULL
host	NULL
of	NULL
other	NULL
agents	NULL
(	NULL
6	NULL
,	NULL
7	NULL
)	NULL
.	NULL

iNOS	NULL
has	NULL
been	NULL
localized	NULL
to	NULL
a	NULL
variety	NULL
of	NULL
cell	NULL
types	NULL
upon	NULL
appropriate	NULL
immunologic	NULL
stimulation	NULL
(	NULL
6	NULL
,	NULL
7	NULL
)	NULL
.	NULL

The	NULL
key	NULL
to	NULL
regulation	NULL
of	NULL
NO	NULL
production	NULL
by	NULL
iNOS	NULL
is	NULL
through	NULL
regulation	NULL
of	NULL
transcription	NULL
(	NULL
8	NULL
,	NULL
9	NULL
)	NULL
.	NULL

The	NULL
publication	NULL
costs	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
page	NULL
charge	NULL
payment	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

§1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

Copyright	NULL
©	NULL
1997	NULL
by	NULL
Tar	NULL
Narronat	NULL
Acapemy	NULL
or	NULL
Sciences	NULL
or	NULL
THE	NULL
USA	NULL
0027-8424	NULL
/97/942676-5	NULL
$	NULL
2.00	NULL
/0	NULL
PNAS	NULL
is	NULL
available	NULL
online	NULL
at	NULL
http	NULL
:	NULL
//www.pnas.org	NULL
.	NULL

2676	NULL
Characterization	NULL
of	NULL
the	NULL
promoter	NULL
region	NULL
of	NULL
the	NULL
gene	NULL
for	NULL
iNOS	NULL
reveals	NULL
a	NULL
complex	NULL
pattern	NULL
of	NULL
regulation	NULL
(	NULL
8-12	NULL
)	NULL
.	NULL

Upstream	NULL
from	NULL
the	NULL
transcription	NULL
start	NULL
site	NULL
are	NULL
distinct	NULL
regulatory	NULL
regions	NULL
,	NULL
including	NULL
LPS-related	NULL
response	NULL
elements	NULL
,	NULL
binding	NULL
sites	NULL
for	NULL
NFxB	NULL
,	NULL
and	NULL
y-interferon	NULL
motifs	NULL
(	NULL
8-11	NULL
)	NULL
.	NULL

Recent	NULL
studies	NULL
indicate	NULL
that	NULL
NO	NULL
transcriptionally	NULL
inhibits	NULL
iNOS	NULL
mRNA	NULL
expression	NULL
in	NULL
astrocytes	NULL
(	NULL
13	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
mechanism	NULL
by	NULL
which	NULL
NO	NULL
transcriptionally	NULL
regulates	NULL
iNOS	NULL
expression	NULL
has	NULL
not	NULL
been	NULL
clarified	NULL
.	NULL

Preliminary	NULL
studies	NULL
showed	NULL
that	NULL
exogenously	NULL
applied	NULL
NO	NULL
inhibits	NULL
the	NULL
activation	NULL
of	NULL
NFxB	NULL
(	NULL
14	NULL
,	NULL
15	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
we	NULL
wondered	NULL
whether	NULL
NO	NULL
inhibition	NULL
of	NULL
NFxB	NULL
could	NULL
regulate	NULL
the	NULL
expression	NULL
of	NULL
iNOS	NULL
.	NULL

We	NULL
now	NULL
report	NULL
that	NULL
endogenous	NULL
NO	NULL
regulates	NULL
the	NULL
transcription	NULL
factor	NULL
NFxB	NULL
,	NULL
and	NULL
through	NULL
this	NULL
regulation	NULL
modulates	NULL
the	NULL
expression	NULL
of	NULL
iNOS	NULL
.	NULL

Moreover	NULL
,	NULL
we	NULL
show	NULL
that	NULL
type	NULL
I	NULL
(	NULL
nNOS	NULL
)	NULL
in	NULL
glia	NULL
tonically	NULL
suppresses	NULL
NFB	NULL
activity	NULL
and	NULL
transcriptionally	NULL
regulates	NULL
iNOS	NULL
expression	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Cell	NULL
Cultures	NULL
.	NULL

Primary	NULL
mixed	NULL
glial	NULL
cell	NULL
cultures	NULL
were	NULL
prepared	NULL
from	NULL
postnatal	NULL
day	NULL
0-3	NULL
Lewis	NULL
rats	NULL
as	NULL
described	NULL
(	NULL
16	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
the	NULL
cortex	NULL
was	NULL
dissected	NULL
under	NULL
a	NULL
microscope	NULL
in	NULL
Brooks-Logan	NULL
dissecting	NULL
solution	NULL
.	NULL

After	NULL
dissection	NULL
,	NULL
the	NULL
cortical	NULL
tissue	NULL
was	NULL
placed	NULL
in	NULL
0.25	NULL
%	NULL
trypsin	NULL
solution	NULL
at	NULL
37°C	NULL
for	NULL
30	NULL
min	NULL
.	NULL

The	NULL
trypsin	NULL
solution	NULL
was	NULL
removed	NULL
,	NULL
and	NULL
DMEM	NULL
(	NULL
GIBCO	NULL
/	NULL
BRL	NULL
)	NULL
with	NULL
20	NULL
%	NULL
fetal	NULL
bovine	NULL
serum	NULL
(	NULL
FBS	NULL
)	NULL
(	NULL
GIBCO/BRL	NULL
)	NULL
and	NULL
2	NULL
mM	NULL
L-glutamine	NULL
(	NULL
GIBCO/BRL	NULL
)	NULL
was	NULL
added	NULL
to	NULL
the	NULL
cortical	NULL
tissue	NULL
suspension	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
dissociated	NULL
by	NULL
trituration	NULL
through	NULL
9-inch	NULL
Pasteur	NULL
pipettes	NULL
until	NULL
the	NULL
solution	NULL
was	NULL
cloudy	NULL
.	NULL

The	NULL
suspended	NULL
cells	NULL
were	NULL
plated	NULL
on	NULL
75-em	NULL
>	NULL
flasks	NULL
coated	NULL
with	NULL
polyornithine	NULL
and	NULL
placed	NULL
in	NULL
an	NULL
8	NULL
%	NULL
CO	NULL
;	NULL
humidified	NULL
37°C	NULL
incubator	NULL
.	NULL

After	NULL
2	NULL
days	NULL
in	NULL
culture	NULL
,	NULL
the	NULL
medium	NULL
was	NULL
changed	NULL
to	NULL
DMEM	NULL
,	NULL
10	NULL
%	NULL
FBS	NULL
,	NULL
and	NULL
2	NULL
mM	NULL
glutamine	NULL
.	NULL

The	NULL
medium	NULL
was	NULL
changed	NULL
twice	NULL
per	NULL
week	NULL
,	NULL
and	NULL
the	NULL
cultures	NULL
were	NULL
allowed	NULL
to	NULL
mature	NULL
to	NULL
confluence	NULL
(	NULL
approximately	NULL
1	NULL
week	NULL
)	NULL
before	NULL
being	NULL
used	NULL
for	NULL
the	NULL
experiments	NULL
.	NULL

To	NULL
examine	NULL
the	NULL
role	NULL
of	NULL
nNOS	NULL
in	NULL
NFxB	NULL
activation	NULL
,	NULL
primary	NULL
mixed	NULL
glial	NULL
cell	NULL
cultures	NULL
also	NULL
were	NULL
prepared	NULL
from	NULL
day	NULL
0-3	NULL
pups	NULL
of	NULL
wild-type	NULL
mice	NULL
and	NULL
mutant	NULL
mice	NULL
lacking	NULL
the	NULL
gene	NULL
for	NULL
nNOS	NULL
(	NULL
17	NULL
)	NULL
.	NULL

Jurkat	NULL
cells	NULL
(	NULL
American	NULL
Abbreviations	NULL
:	NULL
NOS	NULL
,	NULL
nitric	NULL
oxide	NULL
synthase	NULL
;	NULL
nNOS	NULL
,	NULL
neuronal	NULL
NOS	NULL
;	NULL
eNOS	NULL
,	NULL
endothelial	NULL
NOS	NULL
;	NULL
iNOS	NULL
,	NULL
immunologic	NULL
NOS	NULL
;	NULL
NFB	NULL
,	NULL
nuclear	NULL
factor	NULL
«	NULL
B	NULL
;	NULL
PDTC	NULL
,	NULL
pyrrolidine	NULL
dithiocarbamate	NULL
;	NULL
LPS	NULL
,	NULL
lipopolysaccha-ride	NULL
;	NULL
TNF-a	NULL
,	NULL
tumor	NULL
necrosis	NULL
factor-a	NULL
;	NULL
FBS	NULL
,	NULL
fetal	NULL
bovine	NULL
serum	NULL
;	NULL
PMSF	NULL
,	NULL
phenylmethylsulfonyl	NULL
fluoride	NULL
;	NULL
L-Arg	NULL
,	NULL
L-arginine	NULL
;	NULL
BPS	NULL
,	NULL
bathophenanthroline	NULL
disulfonic	NULL
acid	NULL
;	NULL
L-NMMA	NULL
,	NULL
N-monomethylarginine	NULL
;	NULL
NOR-3	NULL
,	NULL
(	NULL
+	NULL
)	NULL
-	NULL
(	NULL
E	NULL
)	NULL
-ethyl-2-	NULL
[	NULL
(	NULL
E	NULL
)	NULL
-hydroxyimino	NULL
]	NULL
-5-nitro-3-hexeneamide	NULL
.	NULL

tPresent	NULL
address	NULL
:	NULL
The	NULL
Second	NULL
Department	NULL
of	NULL
Internal	NULL
Medicine	NULL
,	NULL
Yamagata	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
Yamagata	NULL
,	NULL
Japan	NULL
990-23	NULL
.	NULL

$	NULL
Present	NULL
address	NULL
:	NULL
Department	NULL
of	NULL
Neurology	NULL
,	NULL
University	NULL
of	NULL
Texas	NULL
,	NULL
Dallas	NULL
,	NULL
TX	NULL
75235-9036	NULL
.	NULL

Present	NULL
address	NULL
:	NULL
Department	NULL
of	NULL
Neurology	NULL
,	NULL
Beth	NULL
Israel	NULL
Hospital	NULL
and	NULL
Harvard	NULL
University	NULL
,	NULL
Boston	NULL
,	NULL
MA	NULL
02115	NULL
.	NULL

**To	NULL
whom	NULL
reprint	NULL
requests	NULL
should	NULL
be	NULL
addressed	NULL
at	NULL
:	NULL
Department	NULL
of	NULL
Neurology	NULL
,	NULL
Johns	NULL
Hopkins	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
600	NULL
N.	NULL
Wolfe	NULL
Street	NULL
,	NULL
Path	NULL
2-210	NULL
,	NULL
Baltimore	NULL
,	NULL
MD	NULL
21287.	NULL
e-mail	NULL
:	NULL
valina_dawson	NULL
@	NULL
gmail.bs.jhu.edu	NULL
.	NULL

Neurobiology	NULL
:	NULL
Togashi	NULL
et	NULL
al	NULL
.	NULL

Type	NULL
Culture	NULL
Collection	NULL
)	NULL
were	NULL
grown	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
(	NULL
GIBCO/BRL	NULL
)	NULL
containing	NULL
10	NULL
%	NULL
FBS	NULL
.	NULL

Jurkat	NULL
cells	NULL
were	NULL
plated	NULL
on	NULL
75-em	NULL
flasks	NULL
and	NULL
grown	NULL
in	NULL
a	NULL
5	NULL
%	NULL
CO	NULL
;	NULL
humidified	NULL
37°C	NULL
incubator	NULL
.	NULL

Cultures	NULL
were	NULL
treated	NULL
with	NULL
the	NULL
various	NULL
agents	NULL
as	NULL
indicated	NULL
in	NULL
the	NULL
text	NULL
and	NULL
figure	NULL
legends	NULL
.	NULL

Measurement	NULL
of	NULL
Nitrite	NULL
Formation	NULL
.	NULL

To	NULL
remove	NULL
any	NULL
trace	NULL
of	NULL
phenol	NULL
red	NULL
,	NULL
the	NULL
cell	NULL
cultures	NULL
were	NULL
washed	NULL
gently	NULL
with	NULL
Griess	NULL
medium	NULL
.	NULL

Griess	NULL
medium	NULL
consisted	NULL
of	NULL
DMEM	NULL
without	NULL
glucose	NULL
,	NULL
glutamine	NULL
,	NULL
phenol	NULL
red	NULL
,	NULL
sodium	NULL
bicarbonate	NULL
,	NULL
and	NULL
sodium	NULL
pyru-vate	NULL
with	NULL
the	NULL
following	NULL
additions	NULL
:	NULL
0.4	NULL
mM	NULL
MgSQO4	NULL
,	NULL
20	NULL
mM	NULL
NaHCOs	NULL
,	NULL
12	NULL
mM	NULL
D-glucose	NULL
,	NULL
0.5	NULL
mM	NULL
pyruvic	NULL
acid	NULL
,	NULL
and	NULL
0.4	NULL
mM	NULL
CaCl	NULL
;	NULL
,	NULL
.	NULL

After	NULL
the	NULL
exposure	NULL
period	NULL
,	NULL
culture	NULL
media	NULL
were	NULL
harvested	NULL
for	NULL
the	NULL
colorimetric	NULL
determination	NULL
of	NULL
nitrite	NULL
concentration	NULL
by	NULL
comparison	NULL
to	NULL
nitrite	NULL
standards	NULL
(	NULL
16	NULL
)	NULL
.	NULL

Northern	NULL
Blot	NULL
Analysis	NULL
.	NULL

Total	NULL
cellular	NULL
RNA	NULL
was	NULL
isolated	NULL
from	NULL
cells	NULL
with	NULL
the	NULL
guanidinium	NULL
thiocyanate-phenol-chloroform	NULL
method	NULL
(	NULL
18	NULL
)	NULL
.	NULL

Northern	NULL
blot	NULL
analysis	NULL
was	NULL
done	NULL
as	NULL
described	NULL
(	NULL
19	NULL
)	NULL
.	NULL

Equal	NULL
amounts	NULL
of	NULL
total	NULL
RNA	NULL
(	NULL
5	NULL
pug/lane	NULL
)	NULL
were	NULL
separated	NULL
by	NULL
denaturing	NULL
agarose	NULL
gel	NULL
electrophoresis	NULL
and	NULL
transferred	NULL
to	NULL
positively	NULL
charged	NULL
nylon	NULL
membranes	NULL
(	NULL
Hybond-N	NULL
,	NULL
Amersham	NULL
)	NULL
.	NULL

The	NULL
membrane	NULL
was	NULL
hybridized	NULL
with	NULL
a	NULL
*°P	NULL
-labeled	NULL
random-primed	NULL
probe	NULL
made	NULL
to	NULL
rat	NULL
iNOS	NULL
and	NULL
B-actin	NULL
.	NULL

Hybridized	NULL
filters	NULL
were	NULL
washed	NULL
at	NULL
65°C	NULL
in	NULL
0.1	NULL
%	NULL
standard	NULL
saline	NULL
citrate	NULL
(	NULL
1x	NULL
SSC	NULL
=	NULL
0.15	NULL
M	NULL
sodium	NULL
chloride/0.015	NULL
m	NULL
sodium	NULL
citrate	NULL
,	NULL
pH	NULL
7	NULL
)	NULL
and	NULL
0.1	NULL
%	NULL
SDS	NULL
.	NULL

The	NULL
membrane	NULL
then	NULL
was	NULL
exposed	NULL
to	NULL
a	NULL
PhosphorImager	NULL
(	NULL
Molecular	NULL
Dynamics	NULL
)	NULL
screen	NULL
,	NULL
and	NULL
the	NULL
bands	NULL
were	NULL
quantitated	NULL
.	NULL

Western	NULL
Blot	NULL
Analysis	NULL
.	NULL

Cell	NULL
culture	NULL
plates	NULL
were	NULL
washed	NULL
twice	NULL
with	NULL
ice-cold	NULL
PBS	NULL
.	NULL

Cells	NULL
were	NULL
harvested	NULL
by	NULL
being	NULL
scraped	NULL
into	NULL
ice-cold	NULL
lysis	NULL
buffer	NULL
[	NULL
50	NULL
mM	NULL
TrisHCl	NULL
,	NULL
pH	NULL
7.4/1	NULL
mM	NULL
2-mercaptoethanol/1	NULL
mM	NULL
phenylmethylsulfonyl	NULL
fluoride	NULL
(	NULL
PMSF	NULL
)	NULL
/1	NULL
mM	NULL
benzamidine/10	NULL
pg/ml	NULL
pepstatin	NULL
A/1	NULL
pg/ml	NULL
aprotinin/1	NULL
mM	NULL
EDTA	NULL
]	NULL
.	NULL

The	NULL
cell	NULL
lysate	NULL
was	NULL
transferred	NULL
to	NULL
microcentrifuge	NULL
tubes	NULL
and	NULL
incubated	NULL
on	NULL
ice	NULL
for	NULL
60	NULL
min	NULL
and	NULL
centrifuged	NULL
at	NULL
15,000	NULL
rpm	NULL
for	NULL
20	NULL
min	NULL
at	NULL
4°C	NULL
.	NULL

The	NULL
supernatant	NULL
fluid	NULL
(	NULL
total	NULL
cell	NULL
lysate	NULL
)	NULL
was	NULL
used	NULL
for	NULL
Western	NULL
blot	NULL
analysis	NULL
.	NULL

Western	NULL
blot	NULL
analysis	NULL
was	NULL
carried	NULL
out	NULL
using	NULL
50	NULL
ug	NULL
of	NULL
the	NULL
total	NULL
cell	NULL
lysates	NULL
.	NULL

Proteins	NULL
were	NULL
electroblotted	NULL
from	NULL
SDS-polyacrylamide	NULL
gels	NULL
onto	NULL
Immobilon-P	NULL
membranes	NULL
.	NULL

The	NULL
membrane	NULL
was	NULL
blocked	NULL
with	NULL
5	NULL
%	NULL
skim	NULL
milk	NULL
in	NULL
PBS	NULL
for	NULL
1	NULL
h	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

Affinity-purified	NULL
rabbit	NULL
polyclonal	NULL
antisera	NULL
to	NULL
iNOS	NULL
and	NULL
mouse	NULL
polyclonal	NULL
antiserum	NULL
to	NULL
nNOS	NULL
and	NULL
eNOS	NULL
were	NULL
from	NULL
Transduction	NULL
Laboratories	NULL
(	NULL
Lexington	NULL
,	NULL
KY	NULL
)	NULL
.	NULL

The	NULL
blots	NULL
were	NULL
incubated	NULL
with	NULL
primary	NULL
antibodies	NULL
overnight	NULL
at	NULL
4°C	NULL
in	NULL
PBS	NULL
buffer	NULL
containing	NULL
3	NULL
%	NULL
BSA	NULL
.	NULL

The	NULL
blots	NULL
were	NULL
washed	NULL
four	NULL
times	NULL
with	NULL
5	NULL
%	NULL
skim	NULL
milk	NULL
in	NULL
PBS	NULL
and	NULL
then	NULL
incubated	NULL
with	NULL
secondary	NULL
antibody	NULL
(	NULL
1:5,000	NULL
dilution	NULL
)	NULL
coupled	NULL
to	NULL
horseradish	NULL
peroxidase	NULL
.	NULL

Immunodetection	NULL
was	NULL
accomplished	NULL
using	NULL
a	NULL
Lu-miglo	NULL
Substrate	NULL
Kit	NULL
(	NULL
Kirkegaard	NULL
&	NULL
Perry	NULL
Laboratories	NULL
)	NULL
for	NULL
chemiluminescent	NULL
detection	NULL
.	NULL

Electrophoretic	NULL
Mobility	NULL
Shift	NULL
Assay	NULL
and	NULL
Supershift	NULL
Analysis	NULL
.	NULL

The	NULL
26-mer	NULL
oligonucleotide	NULL
from	NULL
the	NULL
major	NULL
histocompatibility	NULL
complex	NULL
class	NULL
I	NULL
promoter	NULL
,	NULL
including	NULL
the	NULL
consensus	NULL
binding	NULL
site	NULL
for	NULL
NFkB	NULL
(	NULL
5-GATCCAGAGGGGACTTTC-CGAGAGGA-3	NULL
``	NULL
)	NULL
,	NULL
was	NULL
used	NULL
for	NULL
gel	NULL
shifts	NULL
(	NULL
20	NULL
)	NULL
(	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
)	NULL
.	NULL

The	NULL
NFxB	NULL
binding	NULL
oligonucleotide	NULL
was	NULL
end-labeled	NULL
with	NULL
[	NULL
y-*PJATP	NULL
and	NULL
T4	NULL
polynucleotide	NULL
kinase	NULL
(	NULL
New	NULL
England	NULL
Biolabs	NULL
)	NULL
,	NULL
and	NULL
purified	NULL
by	NULL
G-50	NULL
Sephadex	NULL
columns	NULL
(	NULL
Pharmacia	NULL
)	NULL
.	NULL

Confluent	NULL
cultured	NULL
glial	NULL
cells	NULL
and	NULL
Jurkat	NULL
cells	NULL
were	NULL
harvested	NULL
with	NULL
ice-cold	NULL
hypoosmotic	NULL
buffer	NULL
(	NULL
10	NULL
mM	NULL
Hepes	NULL
,	NULL
pH	NULL
7.8/10	NULL
mM	NULL
KCI/2	NULL
mM	NULL
MgCl	NULL
;	NULL
/0.1	NULL
mM	NULL
EDTA/10	NULL
ug/ml	NULL
aprotinin/0.5	NULL
pg/ml	NULL
leupeptin/3	NULL
mM	NULL
PMSF/3	NULL
mM	NULL
DTT	NULL
)	NULL
after	NULL
stimulation	NULL
.	NULL

The	NULL
cells	NULL
in	NULL
the	NULL
hypotonic	NULL
buffer	NULL
were	NULL
incubated	NULL
for	NULL
17	NULL
min	NULL
on	NULL
ice	NULL
.	NULL

Nonidet	NULL
P-40	NULL
was	NULL
added	NULL
,	NULL
and	NULL
the	NULL
nuclei	NULL
were	NULL
pelleted	NULL
by	NULL
centrifugation	NULL
at	NULL
15,000	NULL
rpm	NULL
for	NULL
5	NULL
min	NULL
in	NULL
a	NULL
microcentrifuge	NULL
.	NULL

The	NULL
supernatants	NULL
containing	NULL
the	NULL
cyto-plasmic	NULL
proteins	NULL
were	NULL
removed	NULL
and	NULL
stored	NULL
at	NULL
-70°C	NULL
.	NULL

The	NULL
pelleted	NULL
nuclei	NULL
were	NULL
resuspended	NULL
in	NULL
a	NULL
high-salt	NULL
buffer	NULL
[	NULL
50	NULL
mM	NULL
Hepes	NULL
,	NULL
pH	NULL
7.4/50	NULL
mM	NULL
KCI/300	NULL
mM	NULL
NaCl/0.1	NULL
mM	NULL
EDTA/	NULL
10	NULL
%	NULL
(	NULL
vol/vol	NULL
)	NULL
glycerol/3	NULL
mM	NULL
DTT/3	NULL
mM	NULL
PMSF	NULL
]	NULL
to	NULL
solubilize	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
94	NULL
(	NULL
1997	NULL
)	NULL
2677	NULL
DNA	NULL
binding	NULL
proteins	NULL
.	NULL

The	NULL
resuspended	NULL
nuclei	NULL
were	NULL
gently	NULL
shaken	NULL
for	NULL
30	NULL
min	NULL
at	NULL
4°C	NULL
.	NULL

The	NULL
extracts	NULL
were	NULL
spun	NULL
in	NULL
a	NULL
microcentrifuge	NULL
at	NULL
15,000	NULL
rpm	NULL
for	NULL
10	NULL
min	NULL
,	NULL
and	NULL
the	NULL
clear	NULL
supernatants	NULL
containing	NULL
nuclear	NULL
protein	NULL
were	NULL
aliquoted	NULL
and	NULL
stored	NULL
at	NULL
-70°C	NULL
.	NULL

Binding	NULL
reactions	NULL
were	NULL
performed	NULL
at	NULL
room	NULL
temperature	NULL
for	NULL
15	NULL
min	NULL
using	NULL
6-8	NULL
ug	NULL
of	NULL
nuclear	NULL
protein	NULL
and	NULL
0.25	NULL
ng	NULL
(	NULL
25,000	NULL
cpm	NULL
)	NULL
of	NULL
labeled	NULL
oligonucleotide	NULL
in	NULL
30	NULL
ul	NULL
of	NULL
binding	NULL
buffer	NULL
containing	NULL
10	NULL
mM	NULL
TrisHCl	NULL
,	NULL
pH	NULL
7.5/50	NULL
mM	NULL
NaCI1/50	NULL
mM	NULL
KCl/1	NULL
mM	NULL
MgCl	NULL
;	NULL
/1	NULL
mM	NULL
EDTA/S	NULL
mM	NULL
DTT/5	NULL
%	NULL
glycerol/2	NULL
ug	NULL
of	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
(	NULL
Pharmacia	NULL
)	NULL
.	NULL

DNA-protein	NULL
complexes	NULL
were	NULL
separated	NULL
from	NULL
unbound	NULL
probe	NULL
on	NULL
native	NULL
6.0	NULL
%	NULL
polyacrylamide	NULL
gels	NULL
(	NULL
Bio-Rad	NULL
)	NULL
at	NULL
200-250	NULL
V	NULL
for	NULL
2	NULL
h.	NULL
The	NULL
resultant	NULL
gel	NULL
was	NULL
vacuum-dried	NULL
and	NULL
exposed	NULL
to	NULL
a	NULL
PhosphorImager	NULL
screen	NULL
.	NULL

Cold	NULL
competition	NULL
was	NULL
performed	NULL
using	NULL
consensus	NULL
(	NULL
5'-GGGGACTTTCCC-3	NULL
'	NULL
)	NULL
or	NULL
mutant	NULL
NFB	NULL
subunits	NULL
p65	NULL
and	NULL
p50	NULL
(	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
)	NULL
.	NULL

Supershift	NULL
experiments	NULL
were	NULL
performed	NULL
by	NULL
adding	NULL
NFB	NULL
p65	NULL
or	NULL
p50	NULL
antibody	NULL
(	NULL
1	NULL
or	NULL
2	NULL
wl	NULL
)	NULL
to	NULL
the	NULL
binding	NULL
mixture	NULL
immediately	NULL
after	NULL
the	NULL
addition	NULL
of	NULL
the	NULL
radiolabeled	NULL
NFB	NULL
probe	NULL
.	NULL

The	NULL
reaction	NULL
mixture	NULL
was	NULL
incubated	NULL
for	NULL
20	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
,	NULL
and	NULL
the	NULL
complexes	NULL
were	NULL
resolved	NULL
as	NULL
described	NULL
above	NULL
.	NULL

Statistical	NULL
Analysis	NULL
.	NULL

Data	NULL
were	NULL
analyzed	NULL
using	NULL
one-way	NULL
ANOVA	NULL
,	NULL
followed	NULL
by	NULL
least	NULL
significant	NULL
difference	NULL
post	NULL
hoc	NULL
analysis	NULL
to	NULL
determine	NULL
statistical	NULL
significance	NULL
.	NULL

Differences	NULL
were	NULL
considered	NULL
significant	NULL
at	NULL
P	NULL
<	NULL
0.05	NULL
.	NULL

Chemicals	NULL
.	NULL

LPS	NULL
,	NULL
PDTC	NULL
,	NULL
L-Arg	NULL
,	NULL
bathophenanthroline	NULL
disulfonic	NULL
acid	NULL
(	NULL
BPS	NULL
)	NULL
,	NULL
PMSF	NULL
,	NULL
benzamidine	NULL
,	NULL
leupeptin	NULL
,	NULL
pepstatin	NULL
A	NULL
,	NULL
and	NULL
aprotinin	NULL
were	NULL
obtained	NULL
from	NULL
Sigma	NULL
.	NULL

(	NULL
+	NULL
)	NULL
-	NULL
(	NULL
£	NULL
)	NULL
-Ethyl-2	NULL
[	NULL
(	NULL
EF	NULL
)	NULL
-hydroxyimino	NULL
]	NULL
-5-nitro-3-hexenamide	NULL
(	NULL
NOR-3	NULL
)	NULL
,	NULL
L-NS-	NULL
(	NULL
1-iminoethyl	NULL
)	NULL
ornithine	NULL
,	NULL
and	NULL
N-monomethylarginine	NULL
(	NULL
L-NMMA	NULL
)	NULL
were	NULL
from	NULL
Alexis	NULL
(	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Human	NULL
TNF-a	NULL
was	NULL
from	NULL
Intergen	NULL
(	NULL
Purchase	NULL
,	NULL
NY	NULL
)	NULL
.	NULL

RESULTS	NULL
Endogenous	NULL
NO	NULL
Inhibits	NULL
NFB	NULL
Activation	NULL
.	NULL

To	NULL
evaluate	NULL
the	NULL
role	NULL
of	NULL
endogenously	NULL
produced	NULL
NO	NULL
effects	NULL
on	NULL
NFKB	NULL
transcription	NULL
we	NULL
examined	NULL
the	NULL
effects	NULL
of	NULL
NOS	NULL
inhibitors	NULL
on	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
in	NULL
astrocytes	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

L-NMMA	NULL
(	NULL
500	NULL
mM	NULL
)	NULL
,	NULL
a	NULL
competitive	NULL
NOS	NULL
inhibitor	NULL
,	NULL
begins	NULL
to	NULL
enhance	NULL
NFxB	NULL
binding	NULL
at	NULL
4	NULL
h	NULL
,	NULL
and	NULL
at	NULL
24	NULL
h	NULL
there	NULL
is	NULL
a	NULL
dramatic	NULL
increase	NULL
in	NULL
NFB	NULL
binding	NULL
.	NULL

The	NULL
substrate	NULL
for	NULL
NOS	NULL
,	NULL
L-Arg	NULL
(	NULL
5	NULL
mM	NULL
)	NULL
,	NULL
completely	NULL
reverses	NULL
the	NULL
enhancement	NULL
of	NULL
NFkB	NULL
binding	NULL
by	NULL
A	NULL
L-NMMA	NULL
L-Arg+L-NMMA	NULL
Time	NULL
(	NULL
hr	NULL
)	NULL
Q	NULL
2	NULL
4	NULL
8	NULL
1624	NULL
0	NULL
2	NULL
4	NULL
8	NULL
1624	NULL
nd	NULL
foud	NULL
mae	NULL
<	NULL
NF-	NULL
<	NULL
B	NULL
a	NULL
u	NULL
wean	NULL
b	NULL
a	NULL
a	NULL
a	NULL
a	NULL
be	NULL
<	NULL
550-550	NULL
dimer	NULL
B	NULL
Time	NULL
(	NULL
hr	NULL
)	NULL
__	NULL
2	NULL
4	NULL
8	NULL
16	NULL
24	NULL
LPS	NULL
++	NULL
-oO+	NULL
¢	NULL
COF	NULL
F	NULL
CoO+	NULL
FP	NULL
-	NULL
i	NULL
+	NULL
NOR-3	NULL
``	NULL
z	NULL
_n	NULL
&	NULL
co	NULL
n	NULL
tho	NULL
c	NULL
n	NULL
ton	NULL
nk	NULL
conk	NULL
bei	NULL
Ww	NULL
-	NULL
Woo	NULL
-	NULL
Wh	NULL
-	NULL
Who-Nnp-cB	NULL
-p50-p50	NULL
C	NULL
I	NULL
o	NULL
#	NULL
dimer	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

NO	NULL
regulates	NULL
NFkB	NULL
activity	NULL
as	NULL
determined	NULL
by	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
.	NULL

(	NULL
4	NULL
)	NULL
Cultured	NULL
glia	NULL
were	NULL
incubated	NULL
with	NULL
L-NMMA	NULL
(	NULL
500	NULL
uM	NULL
)	NULL
,	NULL
and	NULL
NFxB-binding	NULL
activity	NULL
was	NULL
measured	NULL
at	NULL
0	NULL
,	NULL
2	NULL
,	NULL
4	NULL
,	NULL
8	NULL
,	NULL
16	NULL
,	NULL
and	NULL
24	NULL
h	NULL
after	NULL
treatment	NULL
.	NULL

L-NMMA	NULL
begins	NULL
to	NULL
enhance	NULL
NFkB	NULL
activity	NULL
at	NULL
4	NULL
h	NULL
,	NULL
and	NULL
at	NULL
24	NULL
h	NULL
there	NULL
is	NULL
a	NULL
dramatic	NULL
increase	NULL
in	NULL
NFxB-binding	NULL
activity	NULL
.	NULL

Excess	NULL
L-Arg	NULL
(	NULL
5	NULL
mM	NULL
)	NULL
completely	NULL
reversed	NULL
L-NMMA-induced	NULL
NFB	NULL
activation	NULL
.	NULL

(	NULL
#	NULL
)	NULL
LPS	NULL
(	NULL
60	NULL
ng/ml	NULL
)	NULL
strongly	NULL
enhances	NULL
NFB	NULL
activity	NULL
in	NULL
glial	NULL
cultures	NULL
.	NULL

LPS	NULL
enhances	NULL
NFB	NULL
activation	NULL
at	NULL
2	NULL
h	NULL
and	NULL
continues	NULL
up	NULL
to	NULL
24	NULL
h	NULL
after	NULL
treatment	NULL
with	NULL
LPS	NULL
.	NULL

NOR-3	NULL
(	NULL
100	NULL
M	NULL
)	NULL
potently	NULL
inhibits	NULL
NFB	NULL
activation	NULL
at	NULL
all	NULL
time	NULL
points	NULL
.	NULL

Representative	NULL
blots	NULL
are	NULL
shown	NULL
for	NULL
experiments	NULL
that	NULL
were	NULL
performed	NULL
at	NULL
least	NULL
three	NULL
independent	NULL
times	NULL
with	NULL
similar	NULL
results	NULL
.	NULL

2678	NULL
Neurobiology	NULL
:	NULL
Togashi	NULL
et	NULL
al	NULL
.	NULL

L-NMMA	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

The	NULL
structurally	NULL
unrelated	NULL
inhibitor	NULL
L-NS-	NULL
(	NULL
1-iminoethyl	NULL
)	NULL
ornithine	NULL
(	NULL
250	NULL
mM	NULL
)	NULL
also	NULL
enhances	NULL
NFB	NULL
binding	NULL
in	NULL
a	NULL
manner	NULL
similar	NULL
to	NULL
L-NMMA	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

To	NULL
confirm	NULL
that	NULL
NO	NULL
inhibits	NULL
NFkB	NULL
transcription	NULL
we	NULL
treated	NULL
astrocytes	NULL
with	NULL
the	NULL
potent	NULL
NF	NULL
kB	NULL
activator	NULL
LPS	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

LPS	NULL
induces	NULL
NFkB	NULL
binding	NULL
at	NULL
2	NULL
h	NULL
with	NULL
maximal	NULL
induction	NULL
at	NULL
4	NULL
h	NULL
,	NULL
which	NULL
is	NULL
sustained	NULL
over	NULL
the	NULL
course	NULL
of	NULL
the	NULL
24-h	NULL
treatment	NULL
with	NULL
LPS	NULL
.	NULL

The	NULL
highly	NULL
selective	NULL
NO	NULL
donor	NULL
,	NULL
NOR-3	NULL
,	NULL
potently	NULL
inhibits	NULL
NFxB	NULL
activation	NULL
at	NULL
all	NULL
time	NULL
points	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

NOR-3	NULL
depleted	NULL
of	NULL
NO	NULL
by	NULL
incubating	NULL
NOR-3	NULL
in	NULL
culture	NULL
media	NULL
for	NULL
several	NULL
hours	NULL
has	NULL
no	NULL
effect	NULL
on	NULL
LPS-induced	NULL
NFB	NULL
activation	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

PDTC	NULL
Differentially	NULL
Regulates	NULL
NFB	NULL
Expression	NULL
in	NULL
Lymphocytes	NULL
and	NULL
Astrocytes	NULL
.	NULL

PDTC	NULL
is	NULL
a	NULL
potent	NULL
inhibitor	NULL
of	NULL
NFB	NULL
activation	NULL
in	NULL
intact	NULL
cells	NULL
(	NULL
20	NULL
)	NULL
.	NULL

However	NULL
,	NULL
PDTC	NULL
is	NULL
also	NULL
a	NULL
potent	NULL
scavenger	NULL
of	NULL
NO	NULL
through	NULL
formation	NULL
of	NULL
mononitrosyl	NULL
iron	NULL
complexes	NULL
with	NULL
PDTC	NULL
(	NULL
21	NULL
,	NULL
22	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
we	NULL
wondered	NULL
whether	NULL
PDTC	NULL
would	NULL
differentially	NULL
regulate	NULL
NFB	NULL
activation	NULL
in	NULL
cells	NULL
that	NULL
constitutively	NULL
express	NULL
NOS	NULL
at	NULL
low	NULL
levels	NULL
(	NULL
23	NULL
)	NULL
versus	NULL
cells	NULL
that	NULL
express	NULL
NOS	NULL
at	NULL
relatively	NULL
higher	NULL
levels	NULL
.	NULL

The	NULL
human	NULL
T-cell	NULL
line	NULL
,	NULL
Jurkat	NULL
cells	NULL
,	NULL
express	NULL
eNOS	NULL
constitutively	NULL
at	NULL
very	NULL
low	NULL
levels	NULL
(	NULL
23	NULL
)	NULL
,	NULL
whereas	NULL
astrocytes	NULL
contain	NULL
relatively	NULL
higher	NULL
levels	NULL
of	NULL
constitutive	NULL
NOS	NULL
(	NULL
24	NULL
)	NULL
.	NULL

Similar	NULL
to	NULL
previous	NULL
reports	NULL
,	NULL
TNF-a	NULL
in	NULL
Jurkat	NULL
cells	NULL
induces	NULL
NFKB	NULL
activation	NULL
at	NULL
30	NULL
min	NULL
,	NULL
which	NULL
diminishes	NULL
over	NULL
time	NULL
to	NULL
modest	NULL
increases	NULL
over	NULL
baseline	NULL
at	NULL
240	NULL
min	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
(	NULL
25	NULL
)	NULL
.	NULL

PDTC	NULL
dramatically	NULL
inhibits	NULL
NFB	NULL
activation	NULL
at	NULL
all	NULL
time	NULL
points	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
PDTC	NULL
does	NULL
not	NULL
inhibit	NULL
TNF-a-induced	NULL
NFKB	NULL
in	NULL
astrocytes	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

Astrocytes	NULL
in	NULL
response	NULL
to	NULL
TNF-a	NULL
have	NULL
sustained	NULL
activation	NULL
of	NULL
NFKB	NULL
and	NULL
also	NULL
appear	NULL
to	NULL
contain	NULL
higher	NULL
levels	NULL
of	NULL
P50	NULL
dimer	NULL
than	NULL
Jurkat	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

PDTC	NULL
Induces	NULL
NFB	NULL
Activation	NULL
in	NULL
Astrocytes	NULL
.	NULL

Because	NULL
PDTC	NULL
fails	NULL
to	NULL
inhibit	NULL
TNF-	NULL
«	NULL
@	NULL
-induced	NULL
NFB	NULL
activation	NULL
in	NULL
astrocytes	NULL
,	NULL
this	NULL
prompted	NULL
us	NULL
to	NULL
further	NULL
evaluate	NULL
the	NULL
effects	NULL
of	NULL
PDTC	NULL
on	NULL
NFKB	NULL
activation	NULL
in	NULL
astrocytes	NULL
.	NULL

LPS	NULL
potently	NULL
activated	NULL
NFB	NULL
binding	NULL
in	NULL
astrocytes	NULL
at	NULL
2	NULL
h	NULL
,	NULL
and	NULL
NFxB	NULL
binding	NULL
continues	NULL
to	NULL
increase	NULL
up	NULL
to	NULL
24	NULL
h	NULL
after	NULL
LPS	NULL
administration	NULL
.	NULL

A	NULL
Jurkat	NULL
cells	NULL
Time	NULL
(	NULL
min	NULL
)	NULL
o	NULL
o	NULL
mo	NULL
Uo	NULL
uo	NULL
&	NULL
.	NULL

<	NULL
p50-p50	NULL
dimer	NULL
Astrocytes	NULL
B	NULL
TNF-a	NULL
___PDTC	NULL
+	NULL
.	NULL

.	NULL

o	NULL
o	NULL
o	NULL
o	NULL
Time	NULL
(	NULL
min	NULL
}	NULL
5	NULL
8	NULL
8	NULL
S	NULL
$	NULL
0	NULL
8	NULL
$	NULL
5	NULL
3	NULL
“	NULL
an	NULL
“	NULL
UH	NULL
NF-	NULL
<	NULL
B	NULL
<	NULL
=	NULL
p50-p50	NULL
dimer	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

PDTC	NULL
differentially	NULL
regulates	NULL
NFxB	NULL
expression	NULL
in	NULL
Jurkat	NULL
cells	NULL
and	NULL
glial	NULL
cultures	NULL
as	NULL
determined	NULL
by	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
.	NULL

(	NULL
4	NULL
)	NULL
In	NULL
Jurkat	NULL
cells	NULL
,	NULL
TNF-a	NULL
(	NULL
300	NULL
units	NULL
per	NULL
ml	NULL
)	NULL
enhances	NULL
NFB	NULL
activity	NULL
,	NULL
which	NULL
peaks	NULL
at	NULL
30	NULL
min	NULL
.	NULL

PDTC	NULL
(	NULL
100	NULL
uM	NULL
)	NULL
inhibits	NULL
TNF-induced	NULL
NFxB	NULL
activation	NULL
at	NULL
all	NULL
time	NULL
points	NULL
.	NULL

Representative	NULL
blots	NULL
are	NULL
shown	NULL
for	NULL
experiments	NULL
that	NULL
were	NULL
performed	NULL
at	NULL
least	NULL
three	NULL
independent	NULL
times	NULL
with	NULL
similar	NULL
results	NULL
.	NULL

(	NULL
#	NULL
)	NULL
TNF-a	NULL
(	NULL
300	NULL
units	NULL
per	NULL
ml	NULL
)	NULL
induces	NULL
NFB	NULL
activation	NULL
in	NULL
cultured	NULL
glia	NULL
.	NULL

PDTC	NULL
(	NULL
100	NULL
pM	NULL
)	NULL
fails	NULL
to	NULL
inhibit	NULL
TNF-a	NULL
(	NULL
300	NULL
units	NULL
per	NULL
ml	NULL
)	NULL
-induced	NULL
NFB	NULL
activation	NULL
.	NULL

Note	NULL
the	NULL
higher	NULL
levels	NULL
of	NULL
P50	NULL
dimer	NULL
in	NULL
glia	NULL
compared	NULL
with	NULL
Jurkat	NULL
cells	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
94	NULL
(	NULL
1997	NULL
)	NULL
Interestingly	NULL
,	NULL
at	NULL
2	NULL
h	NULL
PDTC	NULL
enhances	NULL
LPS-mediated	NULL
activation	NULL
of	NULL
NFB	NULL
.	NULL

The	NULL
enhancement	NULL
of	NULL
LPS-stimulated	NULL
NFB	NULL
binding	NULL
by	NULL
PDTC	NULL
is	NULL
present	NULL
at	NULL
4	NULL
h	NULL
and	NULL
6	NULL
h	NULL
(	NULL
Fig	NULL
.	NULL

34	NULL
)	NULL
.	NULL

At	NULL
8	NULL
to	NULL
24	NULL
h	NULL
PDTC	NULL
modestly	NULL
inhibits	NULL
LPS-stimulated	NULL
NFB	NULL
binding	NULL
(	NULL
Fig	NULL
.	NULL

34	NULL
)	NULL
.	NULL

There	NULL
are	NULL
no	NULL
differences	NULL
in	NULL
cell	NULL
viability	NULL
among	NULL
control	NULL
,	NULL
LPS	NULL
,	NULL
PDTC	NULL
plus	NULL
LPS	NULL
,	NULL
and	NULL
PDTC	NULL
groups	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Strik-ingly	NULL
,	NULL
PDTC	NULL
alone	NULL
activates	NULL
NFxB	NULL
binding	NULL
at	NULL
2	NULL
h	NULL
with	NULL
effects	NULL
diminishing	NULL
at	NULL
6	NULL
h	NULL
of	NULL
PDTC	NULL
treatment	NULL
(	NULL
Fig	NULL
.	NULL

34	NULL
)	NULL
.	NULL

Confirmation	NULL
of	NULL
the	NULL
specificity	NULL
of	NULL
NFB	NULL
activation	NULL
by	NULL
PDTC	NULL
is	NULL
the	NULL
complete	NULL
elimination	NULL
of	NULL
NFxB	NULL
binding	NULL
by	NULL
competition	NULL
with	NULL
unlabeled	NULL
oligonucleotide	NULL
and	NULL
the	NULL
failure	NULL
of	NULL
a	NULL
mutant	NULL
oligonucleotide	NULL
to	NULL
compete	NULL
for	NULL
NFB	NULL
binding	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
anti-P65	NULL
and	NULL
anti-P50	NULL
antibodies	NULL
to	NULL
NFxB	NULL
subunits	NULL
abolish	NULL
the	NULL
NFkB	NULL
band	NULL
and	NULL
cause	NULL
further	NULL
gel	NULL
retardation	NULL
(	NULL
supershift	NULL
)	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

We	NULL
investigated	NULL
the	NULL
potential	NULL
mechanism	NULL
by	NULL
which	NULL
PDTC	NULL
enhances	NULL
NFxB	NULL
binding	NULL
in	NULL
astrocytes	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

PDTC	NULL
is	NULL
an	NULL
effective	NULL
scavenger	NULL
of	NULL
NO	NULL
formation	NULL
as	NULL
indicated	NULL
by	NULL
its	NULL
ability	NULL
to	NULL
inhibit	NULL
nitrite	NULL
formation	NULL
by	NULL
NOR-3	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

PDTC	NULL
enhancement	NULL
of	NULL
NFB	NULL
is	NULL
dose	NULL
dependently	NULL
blocked	NULL
by	NULL
NOR-3	NULL
,	NULL
which	NULL
effectively	NULL
counteracts	NULL
the	NULL
NO-scavenging	NULL
capabilities	NULL
of	NULL
PDTC	NULL
(	NULL
Fig	NULL
.	NULL

3C	NULL
)	NULL
.	NULL

PDTC	NULL
is	NULL
thought	NULL
to	NULL
scavenge	NULL
NO	NULL
through	NULL
forming	NULL
mononitrosyl	NULL
iron	NULL
complexes	NULL
with	NULL
PDTC	NULL
(	NULL
21	NULL
,	NULL
22	NULL
)	NULL
.	NULL

The	NULL
noncell	NULL
permeable	NULL
iron	NULL
chelator	NULL
BPS	NULL
effectively	NULL
inhibits	NULL
PDTC	NULL
enhancement	NULL
of	NULL
NFB	NULL
binding	NULL
(	NULL
Fig	NULL
.	NULL

3D	NULL
)	NULL
,	NULL
confirming	NULL
the	NULL
role	NULL
of	NULL
PDTC	NULL
iron	NULL
complexes	NULL
in	NULL
the	NULL
enhancement	NULL
of	NULL
NFxB	NULL
binding	NULL
A	NULL
Time	NULL
(	NULL
ht	NULL
)	NULL
__2	NULL
4	NULL
6	NULL
a	NULL
16	NULL
LPS	NULL
-+	NULL
%	NULL
-	NULL
-++-	NULL
-	NULL
440	NULL
0	NULL
0	NULL
-++	NULL
%	NULL
-PDTC	NULL
s-ik-	NULL
Kaka	NULL
:	NULL
ZZLLL	NULL
zs-	NULL
&	NULL
L	NULL
uln-	NULL
(	NULL
bu	NULL
bag	NULL
n	NULL
a	NULL
r	NULL
g	NULL
!	NULL

-aNF-xB	NULL
Effect	NULL
of	NULL
PDTC	NULL
on	NULL
Nitrite	NULL
Formation	NULL
20	NULL
€	NULL
ONoRs	NULL
a	NULL
15	NULL
3	NULL
+	NULL
PDTC	NULL
©	NULL
=	NULL
10	NULL
4	NULL
5	NULL
*	NULL
0	NULL
0	NULL
10	NULL
20	NULL
40	NULL
B0	NULL
Concentration	NULL
of	NULL
NOR-3	NULL
(	NULL
1	NULL
M	NULL
)	NULL
C	NULL
D	NULL
PDTC	NULL
0	NULL
100100100100	NULL
uM	NULL
NOR-3	NULL
0	NULL
_o	NULL
10	NULL
50100	NULL
uM	NULL
PDTC	NULL
O	NULL
100	NULL
0	NULL
100	NULL
uM	NULL
BPS	NULL
p	NULL
_	NULL
q	NULL
100100	NULL
uM	NULL
l	NULL
«	NULL
SBE	NULL
cB	NULL
(	NULL
ad	NULL
wo	NULL
uo	NULL
)	NULL
<	NULL
@	NULL
NF-xB	NULL
-K	NULL
was	NULL
s	NULL
©	NULL
==	NULL
is	NULL
Fig	NULL
.	NULL

3	NULL
.	NULL

PDTC	NULL
enhances	NULL
NFxB	NULL
binding	NULL
in	NULL
glia	NULL
by	NULL
scavenging	NULL
NO	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
show	NULL
that	NULL
LPS	NULL
(	NULL
60	NULL
ng/ml	NULL
)	NULL
potently	NULL
activates	NULL
NFxB	NULL
binding	NULL
in	NULL
astrocytes	NULL
at	NULL
2	NULL
h	NULL
,	NULL
and	NULL
this	NULL
activation	NULL
continues	NULL
to	NULL
24	NULL
h.	NULL
PDTC	NULL
(	NULL
100	NULL
uM	NULL
)	NULL
enhances	NULL
LPS-mediated	NULL
NFkB	NULL
activation	NULL
for	NULL
the	NULL
first	NULL
6	NULL
h	NULL
after	NULL
LPS	NULL
administration	NULL
.	NULL

At	NULL
8	NULL
to	NULL
24	NULL
h	NULL
PDTC	NULL
modestly	NULL
inhibits	NULL
LPS-stimulated	NULL
NFB	NULL
binding	NULL
.	NULL

Notably	NULL
,	NULL
PDTC	NULL
(	NULL
100	NULL
M	NULL
)	NULL
alone	NULL
activates	NULL
NFB	NULL
binding	NULL
at	NULL
2	NULL
h	NULL
with	NULL
effects	NULL
diminishing	NULL
at	NULL
6	NULL
h	NULL
of	NULL
PDTC	NULL
treatment	NULL
.	NULL

(	NULL
B	NULL
)	NULL
PDTC	NULL
(	NULL
100	NULL
wM	NULL
)	NULL
significantly	NULL
inhibits	NULL
NOR-3-mediated	NULL
nitrite	NULL
formation	NULL
at	NULL
all	NULL
concentrations	NULL
of	NULL
NOR-3	NULL
.	NULL

Results	NULL
represent	NULL
the	NULL
mean	NULL
of	NULL
five	NULL
independent	NULL
determinations	NULL
+	NULL
the	NULL
SD	NULL
.	NULL

*	NULL
,	NULL
P	NULL
<	NULL
0.01	NULL
as	NULL
compared	NULL
with	NULL
NOR-3	NULL
alone	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
indicate	NULL
that	NULL
NOR-3	NULL
(	NULL
10-100	NULL
LM	NULL
)	NULL
blocks	NULL
PDTC	NULL
{	NULL
100	NULL
pM	NULL
)	NULL
enhancement	NULL
of	NULL
NFB	NULL
activity	NULL
by	NULL
effectively	NULL
counteracting	NULL
the	NULL
NO-scavenging	NULL
capabilities	NULL
of	NULL
PDTC	NULL
.	NULL

(	NULL
D	NULL
)	NULL
Electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
demonstrate	NULL
that	NULL
BPS	NULL
(	NULL
100	NULL
M	NULL
)	NULL
effectively	NULL
inhibits	NULL
PDTC	NULL
{	NULL
100	NULL
uM	NULL
)	NULL
enhancement	NULL
of	NULL
NFB	NULL
activity	NULL
in	NULL
astrocytes	NULL
.	NULL

4	NULL
,	NULL
C	NULL
,	NULL
and	NULL
D	NULL
are	NULL
representative	NULL
of	NULL
at	NULL
least	NULL
three	NULL
independent	NULL
experiments	NULL
.	NULL

Neurobiology	NULL
:	NULL
Togashi	NULL
et	NULL
al	NULL
.	NULL

in	NULL
astrocytes	NULL
.	NULL

BPS	NULL
alone	NULL
has	NULL
minimal	NULL
effects	NULL
on	NULL
NFxB	NULL
binding	NULL
in	NULL
astrocytes	NULL
(	NULL
Fig	NULL
.	NULL

3D	NULL
)	NULL
;	NULL
however	NULL
,	NULL
we	NULL
can	NULL
not	NULL
exclude	NULL
the	NULL
possibility	NULL
that	NULL
BPS	NULL
is	NULL
acting	NULL
as	NULL
a	NULL
scavenger	NULL
of	NULL
NO	NULL
.	NULL

Although	NULL
our	NULL
results	NULL
suggest	NULL
that	NULL
PDTC	NULL
is	NULL
enhancing	NULL
NFB	NULL
activity	NULL
through	NULL
scavenging	NULL
of	NULL
NO	NULL
through	NULL
the	NULL
formation	NULL
of	NULL
mononitrosyl	NULL
iron	NULL
complexes	NULL
,	NULL
we	NULL
can	NULL
not	NULL
exclude	NULL
the	NULL
possibility	NULL
that	NULL
it	NULL
is	NULL
inhibiting	NULL
superoxide	NULL
dismutase	NULL
or	NULL
inhibiting	NULL
the	NULL
Fenton	NULL
reaction	NULL
.	NULL

Constitutive	NULL
NOS	NULL
Regulates	NULL
iNOS	NULL
Expression	NULL
.	NULL

To	NULL
explore	NULL
the	NULL
physiologic	NULL
relevance	NULL
of	NULL
NO-regulated	NULL
NFKB	NULL
transcription	NULL
we	NULL
examined	NULL
the	NULL
effects	NULL
of	NULL
PDTC	NULL
on	NULL
the	NULL
NFKB-regulated	NULL
gene	NULL
,	NULL
iNOS	NULL
(	NULL
8-12	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

44	NULL
)	NULL
.	NULL

PDTC	NULL
dramatically	NULL
induces	NULL
iNOS	NULL
expression	NULL
in	NULL
astrocytes	NULL
with	NULL
iNOS	NULL
protein	NULL
being	NULL
detectable	NULL
at	NULL
4	NULL
h	NULL
after	NULL
PDTC	NULL
treatment	NULL
.	NULL

Maximal	NULL
iNOS	NULL
protein	NULL
levels	NULL
are	NULL
present	NULL
at	NULL
8	NULL
h	NULL
and	NULL
begin	NULL
to	NULL
diminish	NULL
at	NULL
16	NULL
h	NULL
with	NULL
almost	NULL
complete	NULL
loss	NULL
of	NULL
iNOS	NULL
levels	NULL
after	NULL
24	NULL
h	NULL
of	NULL
PDTC	NULL
treatment	NULL
(	NULL
Fig	NULL
.	NULL

44	NULL
)	NULL
.	NULL

To	NULL
further	NULL
examine	NULL
the	NULL
role	NULL
of	NULL
PDTC	NULL
regulation	NULL
of	NULL
NFB	NULL
and	NULL
iNOS	NULL
we	NULL
examined	NULL
the	NULL
effects	NULL
of	NULL
PDTC	NULL
on	NULL
LPS-stimulated	NULL
NO	NULL
formation	NULL
by	NULL
iNOS	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
B-D	NULL
)	NULL
.	NULL

Similar	NULL
to	NULL
previous	NULL
observations	NULL
LPS	NULL
potently	NULL
stimulates	NULL
NO	NULL
formation	NULL
in	NULL
astrocyte	NULL
cultures	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
.	NULL

Consistent	NULL
with	NULL
the	NULL
notion	NULL
that	NULL
PDTC	NULL
scavenges	NULL
NO	NULL
and	NULL
enhances	NULL
NFB	NULL
activity	NULL
is	NULL
the	NULL
ability	NULL
of	NULL
PDTC	NULL
to	NULL
diminish	NULL
nitrite	NULL
levels	NULL
in	NULL
LPS-stimulated	NULL
cultures	NULL
without	NULL
affecting	NULL
the	NULL
levels	NULL
of	NULL
iNOS	NULL
mRNA	NULL
or	NULL
protein	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
B-D	NULL
)	NULL
.	NULL

nNOS	NULL
Regulates	NULL
NFB	NULL
Transcription	NULL
in	NULL
Astrocytes	NULL
.	NULL

To	NULL
ascertain	NULL
the	NULL
source	NULL
of	NULL
NO	NULL
that	NULL
accounts	NULL
for	NULL
regulation	NULL
of	NULL
NFkB	NULL
transcription	NULL
we	NULL
conducted	NULL
Western	NULL
blot	NULL
analysis	NULL
on	NULL
glial	NULL
cultures	NULL
.	NULL

Glia	NULL
constitutively	NULL
express	NULL
nNOS	NULL
and	NULL
contain	NULL
barely	NULL
detectable	NULL
levels	NULL
of	NULL
eNOS	NULL
,	NULL
and	NULL
at	NULL
baseline	NULL
iNOS	NULL
is	NULL
undetectable	NULL
(	NULL
Fig	NULL
.	NULL

54	NULL
)	NULL
.	NULL

Because	NULL
nNOS	NULL
is	NULL
the	NULL
major	NULL
isoform	NULL
that	NULL
is	NULL
constitutively	NULL
expressed	NULL
,	NULL
we	NULL
examined	NULL
the	NULL
effects	NULL
of	NULL
PDTC	NULL
modulation	NULL
of	NULL
NFxB	NULL
transcription	NULL
in	NULL
cultures	NULL
derived	NULL
from	NULL
mice	NULL
lacking	NULL
the	NULL
gene	NULL
for	NULL
nNOS	NULL
and	NULL
compared	NULL
it	NULL
to	NULL
cultures	NULL
derived	NULL
from	NULL
wild-type	NULL
animals	NULL
.	NULL

As	NULL
previously	NULL
shown	NULL
,	NULL
PDTC	NULL
induces	NULL
NFB	NULL
activation	NULL
in	NULL
wild-type	NULL
cultures	NULL
at	NULL
120	NULL
min	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
PDTC	NULL
in	NULL
nNOS	NULL
astrocyte	NULL
cultures	NULL
massively	NULL
induces	NULL
NFxB	NULL
after	NULL
30	NULL
min	NULL
of	NULL
treatment	NULL
,	NULL
and	NULL
at	NULL
2	NULL
h	NULL
NFkB	NULL
is	NULL
dramatically	NULL
induced	NULL
when	NULL
compared	NULL
with	NULL
wild-type	NULL
animals	NULL
A	NULL
PDTC	NULL
C	NULL
_	NULL
LPS-	NULL
++	NULL
Time	NULL
(	NULL
hr	NULL
)	NULL
0	NULL
2	NULL
4	NULL
6	NULL
816	NULL
24PC	NULL
PP	NULL
b	NULL
i+	NULL
f10-	NULL
am-	NULL
s-	NULL
<	NULL
iNOS	NULL
B	NULL
38	NULL
25°	NULL
\	NULL
WW	NULL
Lincs	NULL
25	NULL
185	NULL
3	NULL
20	NULL
3.	NULL
o	NULL
15	NULL
B-actin	NULL
®	NULL
=	NULL
=	NULL
S	NULL
D	NULL
z	NULL
10	NULL
LPS	NULL
1	NULL
4	NULL
i	NULL
PDTC	NULL
-	NULL
.	NULL

-	NULL
.	NULL

+	NULL
5	NULL
a	NULL
216	NULL
oo	NULL
--	NULL
_	NULL
=iNOS	NULL
0	NULL
T	NULL
110	NULL
cont	NULL
PDTC	NULL
LPS	NULL
PDTC	NULL
=	NULL
+LPS	NULL
71	NULL
FiG	NULL
.	NULL

4	NULL
.	NULL

Regulation	NULL
of	NULL
iNOS	NULL
expression	NULL
by	NULL
constitutive	NULL
NOS	NULL
.	NULL

(	NULL
4	NULL
)	NULL
Western	NULL
blot	NULL
analysis	NULL
indicates	NULL
that	NULL
PDTC	NULL
(	NULL
100	NULL
uM	NULL
)	NULL
dramatically	NULL
induces	NULL
iNOS	NULL
expression	NULL
in	NULL
glial	NULL
cultures	NULL
with	NULL
iNOS	NULL
protein	NULL
being	NULL
detectable	NULL
at	NULL
4	NULL
h	NULL
and	NULL
peaking	NULL
at	NULL
8	NULL
h	NULL
after	NULL
PDTC	NULL
treatment	NULL
.	NULL

PC	NULL
,	NULL
positive	NULL
control	NULL
.	NULL

(	NULL
B	NULL
)	NULL
PDTC	NULL
(	NULL
100	NULL
pum	NULL
)	NULL
alone	NULL
significantly	NULL
suppresses	NULL
basal	NULL
nitrite	NULL
formation	NULL
compared	NULL
with	NULL
control	NULL
(	NULL
*	NULL
,	NULL
P	NULL
<	NULL
0.05	NULL
)	NULL
.	NULL

PDTC	NULL
also	NULL
significantly	NULL
inhibits	NULL
LPS	NULL
(	NULL
24	NULL
h	NULL
)	NULL
-stimulated	NULL
nitrite	NULL
formation	NULL
compared	NULL
with	NULL
LPS	NULL
alone	NULL
(	NULL
**	NULL
,	NULL
P	NULL
<	NULL
0.01	NULL
)	NULL
.	NULL

Results	NULL
represent	NULL
the	NULL
mean	NULL
of	NULL
five	NULL
independent	NULL
determination	NULL
+	NULL
SD	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Northern	NULL
blot	NULL
analysis	NULL
shows	NULL
that	NULL
PDTC	NULL
did	NULL
not	NULL
affect	NULL
the	NULL
level	NULL
of	NULL
iNOS	NULL
mRNA	NULL
induced	NULL
by	NULL
LPS	NULL
(	NULL
24	NULL
h	NULL
)	NULL
.	NULL

(	NULL
D	NULL
)	NULL
Western	NULL
blot	NULL
analysis	NULL
shows	NULL
that	NULL
PDTC	NULL
did	NULL
not	NULL
affect	NULL
the	NULL
level	NULL
of	NULL
iNOS	NULL
protein	NULL
induced	NULL
by	NULL
LPS	NULL
(	NULL
24	NULL
h	NULL
)	NULL
.	NULL

4	NULL
,	NULL
C	NULL
,	NULL
and	NULL
D	NULL
are	NULL
representative	NULL
of	NULL
at	NULL
least	NULL
three	NULL
independent	NULL
experiments	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
94	NULL
(	NULL
1997	NULL
)	NULL
2679	NULL
nNOS	NULL
eNOS	NULL
iNOS	NULL
216	NULL
-	NULL
a	NULL
mee	NULL
«	NULL
nNOS	NULL
\l	NULL
«	NULL
eNOS	NULL
110-	NULL
~	NULL
i	NULL
B	NULL
_	NULL
__PDTC	NULL
_	NULL
C	NULL
PDTC	NULL
.	NULL

Wild	NULL
type	NULL
nNOS	NULL
FiG	NULL
.	NULL

5.	NULL
nNOS	NULL
regulates	NULL
NFB	NULL
activation	NULL
in	NULL
glial	NULL
cultures	NULL
.	NULL

(	NULL
4	NULL
)	NULL
Western	NULL
blot	NULL
analysis	NULL
indicates	NULL
that	NULL
glia	NULL
constitutively	NULL
express	NULL
nNOS	NULL
and	NULL
contain	NULL
barely	NULL
detectable	NULL
levels	NULL
of	NULL
eNOS	NULL
,	NULL
and	NULL
at	NULL
baseline	NULL
iNOS	NULL
is	NULL
undetectable	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
demonstrate	NULL
that	NULL
in	NULL
wild-type	NULL
glial	NULL
cultures	NULL
PDTC	NULL
(	NULL
100	NULL
uM	NULL
)	NULL
induces	NULL
NFkB	NULL
activation	NULL
at	NULL
120	NULL
min	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
show	NULL
that	NULL
in	NULL
nNOS~	NULL
glial	NULL
cultures	NULL
PDTC	NULL
massively	NULL
induces	NULL
NFB	NULL
activation	NULL
after	NULL
30	NULL
min	NULL
of	NULL
treatment	NULL
,	NULL
and	NULL
the	NULL
induction	NULL
continues	NULL
until	NULL
2	NULL
h.	NULL
Blots	NULL
are	NULL
representative	NULL
of	NULL
at	NULL
least	NULL
two	NULL
independent	NULL
experiments	NULL
.	NULL

(	NULL
Fig	NULL
.	NULL

5C	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
NO	NULL
derived	NULL
from	NULL
the	NULL
neuronal	NULL
form	NULL
of	NULL
NOS	NULL
seems	NULL
to	NULL
be	NULL
a	NULL
major	NULL
regulator	NULL
of	NULL
NFxB	NULL
transcription	NULL
in	NULL
glial	NULL
cultures	NULL
.	NULL

DISCUSSION	NULL
Our	NULL
findings	NULL
indicate	NULL
that	NULL
NO	NULL
derived	NULL
from	NULL
type	NULL
1	NULL
(	NULL
nNOS	NULL
)	NULL
in	NULL
glia	NULL
inhibits	NULL
NFKB	NULL
activation	NULL
,	NULL
confirming	NULL
previous	NULL
reports	NULL
that	NULL
exogenous	NULL
NO	NULL
can	NULL
regulate	NULL
and	NULL
inhibit	NULL
NFB	NULL
activity	NULL
(	NULL
14	NULL
,	NULL
15	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
we	NULL
show	NULL
that	NULL
endogenously	NULL
derived	NULL
NO	NULL
inhibits	NULL
NFxB-binding	NULL
activity	NULL
,	NULL
because	NULL
competitive	NULL
NOS	NULL
inhibitors	NULL
enhance	NULL
NFB	NULL
binding	NULL
,	NULL
and	NULL
excess	NULL
substrate	NULL
L-Arg	NULL
reverses	NULL
the	NULL
enhancement	NULL
of	NULL
NFxB	NULL
binding	NULL
by	NULL
NOS	NULL
inhibitors	NULL
in	NULL
intact	NULL
cells	NULL
.	NULL

PDTC	NULL
,	NULL
a	NULL
well	NULL
known	NULL
inhibitor	NULL
of	NULL
NFB	NULL
binding	NULL
in	NULL
nonneuronal	NULL
tissue	NULL
(	NULL
20	NULL
)	NULL
,	NULL
enhances	NULL
NFxB	NULL
binding	NULL
in	NULL
astrocytes	NULL
through	NULL
scavenging	NULL
of	NULL
NO	NULL
.	NULL

This	NULL
activation	NULL
of	NULL
NFkB	NULL
induces	NULL
iNOS	NULL
expression	NULL
in	NULL
astrocytes	NULL
.	NULL

The	NULL
source	NULL
of	NULL
endogenously	NULL
derived	NULL
NO	NULL
that	NULL
regulates	NULL
NFxB	NULL
binding	NULL
in	NULL
astrocytes	NULL
appears	NULL
to	NULL
be	NULL
nNOS	NULL
as	NULL
astrocytes	NULL
predominantly	NULL
express	NULL
nNOS	NULL
and	NULL
contain	NULL
negligible	NULL
quantities	NULL
of	NULL
eNOS	NULL
and	NULL
iNOS	NULL
.	NULL

NFB	NULL
binding	NULL
is	NULL
also	NULL
more	NULL
effectively	NULL
induced	NULL
at	NULL
an	NULL
earlier	NULL
time	NULL
point	NULL
by	NULL
the	NULL
NO	NULL
scavenging	NULL
effects	NULL
of	NULL
PDTC	NULL
in	NULL
mutant	NULL
mice	NULL
lacking	NULL
nNOS	NULL
when	NULL
compared	NULL
with	NULL
wild-type	NULL
mice	NULL
.	NULL

One	NULL
pathway	NULL
toward	NULL
NFxB	NULL
binding	NULL
activity	NULL
is	NULL
its	NULL
transloca-tion	NULL
to	NULL
the	NULL
nucleus	NULL
through	NULL
degradation	NULL
of	NULL
inhibitory	NULL
protein	NULL
«	NULL
B	NULL
(	NULL
IxB	NULL
)	NULL
(	NULL
26	NULL
,	NULL
27	NULL
)	NULL
.	NULL

Although	NULL
it	NULL
is	NULL
not	NULL
well	NULL
clarified	NULL
,	NULL
IxB	NULL
degradation	NULL
is	NULL
regulated	NULL
by	NULL
serine	NULL
phosphorylation	NULL
and	NULL
ubiquination	NULL
(	NULL
27	NULL
)	NULL
.	NULL

Recent	NULL
studies	NULL
suggest	NULL
that	NULL
exogenously	NULL
applied	NULL
NO	NULL
may	NULL
inhibit	NULL
NFB	NULL
binding	NULL
in	NULL
endothelial	NULL
cells	NULL
through	NULL
stabilization	NULL
of	NULL
IkB-a	NULL
or	NULL
through	NULL
increased	NULL
transcription	NULL
of	NULL
IkB-a	NULL
(	NULL
14	NULL
)	NULL
.	NULL

Alternatively	NULL
NO	NULL
may	NULL
directly	NULL
inhibit	NULL
NFB	NULL
through	NULL
S-nitrosylation	NULL
of	NULL
the	NULL
cysteine-62	NULL
residue	NULL
of	NULL
p50	NULL
(	NULL
28	NULL
)	NULL
.	NULL

PDTC	NULL
is	NULL
a	NULL
potent	NULL
inhibitor	NULL
of	NULL
NFB	NULL
binding	NULL
in	NULL
nonneuronal	NULL
tissue	NULL
such	NULL
as	NULL
Jurkat	NULL
cells	NULL
(	NULL
25	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
PDTC	NULL
fails	NULL
to	NULL
inhibit	NULL
NFB	NULL
binding	NULL
in	NULL
astrocytes	NULL
after	NULL
either	NULL
TNF-a	NULL
@	NULL
-	NULL
or	NULL
LPS-induced	NULL
NFkB	NULL
binding	NULL
.	NULL

PDTC	NULL
suppression	NULL
of	NULL
NFB	NULL
binding	NULL
in	NULL
nonneuronal	NULL
tissues	NULL
is	NULL
thought	NULL
to	NULL
be	NULL
due	NULL
to	NULL
inhibition	NULL
of	NULL
the	NULL
release	NULL
of	NULL
IxB	NULL
through	NULL
either	NULL
its	NULL
metal	NULL
chelating	NULL
or	NULL
antioxidative	NULL
properties	NULL
.	NULL

The	NULL
molecular	NULL
mechanisms	NULL
underlying	NULL
the	NULL
differential	NULL
regulation	NULL
of	NULL
NFkB	NULL
in	NULL
astrocytes	NULL
versus	NULL
lymphocytes	NULL
is	NULL
not	NULL
known	NULL
.	NULL

It	NULL
is	NULL
possible	NULL
that	NULL
the	NULL
inability	NULL
of	NULL
PDTC	NULL
to	NULL
enhance	NULL
NFkB	NULL
binding	NULL
in	NULL
lymphocytes	NULL
may	NULL
be	NULL
2680	NULL
Neurobiology	NULL
:	NULL
Togashi	NULL
et	NULL
al	NULL
.	NULL

related	NULL
to	NULL
the	NULL
relatively	NULL
low	NULL
levels	NULL
of	NULL
constitutive	NULL
expression	NULL
of	NULL
NOS	NULL
in	NULL
this	NULL
cell	NULL
line	NULL
.	NULL

Alternatively	NULL
,	NULL
the	NULL
relatively	NULL
low	NULL
levels	NULL
of	NULL
P50	NULL
in	NULL
Jurkat	NULL
cells	NULL
(	NULL
25	NULL
)	NULL
in	NULL
contrast	NULL
to	NULL
the	NULL
high	NULL
levels	NULL
of	NULL
P50	NULL
in	NULL
astrocytes	NULL
may	NULL
account	NULL
for	NULL
the	NULL
differential	NULL
regulation	NULL
of	NULL
NFB	NULL
binding	NULL
by	NULL
PDTC	NULL
.	NULL

nNOS	NULL
is	NULL
primarily	NULL
localized	NULL
to	NULL
neurons	NULL
throughout	NULL
the	NULL
peripheral	NULL
and	NULL
central	NULL
nervous	NULL
system	NULL
(	NULL
29	NULL
)	NULL
.	NULL

Recent	NULL
studies	NULL
indicate	NULL
that	NULL
nNOS	NULL
is	NULL
also	NULL
localized	NULL
in	NULL
skeletal	NULL
muscle	NULL
,	NULL
pancreatic	NULL
islets	NULL
,	NULL
endometrium	NULL
,	NULL
and	NULL
respiratory	NULL
and	NULL
gastrointestinal	NULL
epithelium	NULL
(	NULL
4	NULL
)	NULL
.	NULL

nNOS	NULL
in	NULL
neurons	NULL
may	NULL
play	NULL
a	NULL
role	NULL
in	NULL
neurotransmitter	NULL
release	NULL
,	NULL
neural	NULL
development	NULL
,	NULL
synaptic	NULL
plas-ticity	NULL
,	NULL
and	NULL
regulation	NULL
of	NULL
gene	NULL
expression	NULL
.	NULL

Previous	NULL
reports	NULL
indicated	NULL
constitutive	NULL
expression	NULL
of	NULL
NOS	NULL
in	NULL
astrocytes	NULL
(	NULL
24	NULL
)	NULL
;	NULL
however	NULL
,	NULL
the	NULL
isoform	NULL
and	NULL
physiologic	NULL
role	NULL
of	NULL
NOS	NULL
in	NULL
astrocytes	NULL
was	NULL
not	NULL
clarified	NULL
.	NULL

We	NULL
show	NULL
that	NULL
nNOS	NULL
is	NULL
the	NULL
predominant	NULL
isoform	NULL
in	NULL
astrocytes	NULL
,	NULL
implicating	NULL
nNOS	NULL
in	NULL
a	NULL
new	NULL
physiologic	NULL
role	NULL
.	NULL

nNOS	NULL
in	NULL
astrocytes	NULL
constitutively	NULL
generates	NULL
NO	NULL
to	NULL
repress	NULL
the	NULL
NFB	NULL
redox-sensitive	NULL
transcription	NULL
factor	NULL
and	NULL
regulates	NULL
the	NULL
expression	NULL
of	NULL
genes	NULL
such	NULL
as	NULL
iNOS	NULL
.	NULL

Because	NULL
NFB	NULL
regulates	NULL
the	NULL
transcription	NULL
of	NULL
several	NULL
``	NULL
inflam-matory	NULL
``	NULL
genes	NULL
such	NULL
as	NULL
iNOS	NULL
,	NULL
interleukin-6	NULL
,	NULL
TNF-a	NULL
,	NULL
and	NULL
major	NULL
histocompatibility	NULL
complex	NULL
class	NULL
I	NULL
and	NULL
II	NULL
(	NULL
30	NULL
)	NULL
,	NULL
constitutive	NULL
NO	NULL
derived	NULL
from	NULL
nNOS	NULL
in	NULL
astrocytes	NULL
may	NULL
tonically	NULL
inhibit	NULL
inflammatory	NULL
processes	NULL
through	NULL
gene	NULL
regulation	NULL
.	NULL

Consistent	NULL
with	NULL
this	NULL
notion	NULL
are	NULL
our	NULL
observations	NULL
that	NULL
scavenging	NULL
of	NULL
NO	NULL
and	NULL
inhibition	NULL
of	NULL
NOS	NULL
activates	NULL
NFB	NULL
binding	NULL
and	NULL
induces	NULL
iNOS	NULL
.	NULL

Furthermore	NULL
,	NULL
NFKB	NULL
activation	NULL
is	NULL
readily	NULL
induced	NULL
in	NULL
astrocytes	NULL
from	NULL
mice	NULL
lacking	NULL
the	NULL
gene	NULL
for	NULL
nNOS	NULL
.	NULL

Thus	NULL
,	NULL
NO	NULL
derived	NULL
from	NULL
nNOS	NULL
in	NULL
glia	NULL
subserves	NULL
a	NULL
novel	NULL
redox-signaling	NULL
role	NULL
through	NULL
regulation	NULL
of	NULL
NFB	NULL
activity	NULL
.	NULL

NO	NULL
may	NULL
be	NULL
regulating	NULL
NFkB	NULL
through	NULL
both	NULL
intracellular	NULL
and	NULL
intercellular	NULL
signaling	NULL
.	NULL

In	NULL
the	NULL
nervous	NULL
system	NULL
astrocytes	NULL
may	NULL
be	NULL
regulating	NULL
NFKB	NULL
through	NULL
NO	NULL
acting	NULL
intercellularly	NULL
.	NULL

However	NULL
,	NULL
the	NULL
major	NULL
source	NULL
of	NULL
NO	NULL
in	NULL
vivo	NULL
would	NULL
be	NULL
derived	NULL
from	NULL
nNOS	NULL
containing	NULL
neurons	NULL
,	NULL
which	NULL
could	NULL
regulate	NULL
NFxB	NULL
through	NULL
cell-to-cell	NULL
signaling	NULL
.	NULL

Because	NULL
NO	NULL
is	NULL
a	NULL
freely	NULL
diffusible	NULL
messenger	NULL
molecule	NULL
,	NULL
NO	NULL
could	NULL
regulate	NULL
NFB	NULL
through	NULL
intracellular	NULL
interactions	NULL
in	NULL
nonneuronal	NULL
tissue	NULL
as	NULL
well	NULL
.	NULL

These	NULL
observations	NULL
may	NULL
have	NULL
clinical	NULL
relevance	NULL
in	NULL
which	NULL
inhibition	NULL
of	NULL
NOS	NULL
is	NULL
contemplated	NULL
in	NULL
diseases	NULL
such	NULL
as	NULL
multiple	NULL
sclerosis	NULL
(	NULL
31	NULL
)	NULL
and	NULL
severe	NULL
AIDS	NULL
dementia	NULL
(	NULL
32	NULL
)	NULL
where	NULL
iNOS	NULL
is	NULL
elevated	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
U.S.	NULL
Public	NULL
Health	NULL
Service	NULL
Grants	NULL
NS	NULL
01578	NULL
(	NULL
T.M.D	NULL
.	NULL
)	NULL

and	NULL
NS	NULL
22643	NULL
(	NULL
T.M.D	NULL
.	NULL

and	NULL
V.L.D	NULL
.	NULL
)	NULL

and	NULL
by	NULL
the	NULL
American	NULL
Foundation	NULL
for	NULL
AIDS	NULL
Research	NULL
(	NULL
V.L.D	NULL
.	NULL
)	NULL

.	NULL

1	NULL
.	NULL

Moncada	NULL
,	NULL
S.	NULL
&	NULL
Higgs	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
N.	NULL
Engl	NULL
.	NULL

J.	NULL
Med	NULL
.	NULL

329	NULL
,	NULL
2002-2012	NULL
.	NULL

2	NULL
.	NULL

Nathan	NULL
,	NULL
C.	NULL
(	NULL
1992	NULL
)	NULL
FASEB	NULL
J	NULL
.	NULL

6	NULL
,	NULL
3051-3064	NULL
.	NULL

3	NULL
.	NULL

Bredt	NULL
,	NULL
D.	NULL
S.	NULL
&	NULL
Snyder	NULL
,	NULL
S.	NULL
H.	NULL
(	NULL
1994	NULL
)	NULL
Annu	NULL
.	NULL

Rev	NULL
.	NULL

Biochem	NULL
.	NULL

63	NULL
,	NULL
175-195	NULL
.	NULL

4	NULL
.	NULL

Yun	NULL
,	NULL
H.	NULL
Y.	NULL
,	NULL
Dawson	NULL
,	NULL
V.	NULL
L.	NULL
&	NULL
Dawson	NULL
,	NULL
T.	NULL
M.	NULL
(	NULL
1996	NULL
)	NULL
Crit	NULL
.	NULL

Rev	NULL
.	NULL

Neurobiol	NULL
.	NULL

10	NULL
,	NULL
291-316	NULL
.	NULL

10	NULL
.	NULL

11	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
94	NULL
(	NULL
1997	NULL
)	NULL
Dinerman	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
Dawson	NULL
,	NULL
T.	NULL
M.	NULL
,	NULL
Schell	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
Snowman	NULL
,	NULL
A	NULL
.	NULL

&	NULL
Snyder	NULL
,	NULL
S.	NULL
H.	NULL
(	NULL
1994	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
91	NULL
,	NULL
4214-4218	NULL
.	NULL

Nathan	NULL
,	NULL
C.	NULL
&	NULL
Xie	NULL
,	NULL
Q.-W.	NULL
(	NULL
1994	NULL
)	NULL
Cell	NULL
78	NULL
,	NULL
915-918	NULL
.	NULL

Morris	NULL
,	NULL
S.	NULL
M.	NULL
&	NULL
Billiar	NULL
,	NULL
T.	NULL
R.	NULL
(	NULL
1994	NULL
)	NULL
Am	NULL
.	NULL

J.	NULL
Physiol	NULL
.	NULL

266	NULL
,	NULL
E829-E839	NULL
.	NULL

Lowenstein	NULL
,	NULL
C.	NULL
J.	NULL
,	NULL
Alley	NULL
,	NULL
E.	NULL
W.	NULL
,	NULL
Raval	NULL
,	NULL
P.	NULL
,	NULL
Snowman	NULL
,	NULL
A.	NULL
M.	NULL
&	NULL
Snyder	NULL
,	NULL
S.	NULL
H.	NULL
(	NULL
1993	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
89	NULL
,	NULL
6711-6715	NULL
.	NULL

Xie	NULL
,	NULL
Q.-W.	NULL
,	NULL
Whisnant	NULL
,	NULL
R.	NULL
&	NULL
Nathan	NULL
,	NULL
C.	NULL
(	NULL
1993	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

177	NULL
,	NULL
1779-1784	NULL
.	NULL

Martin	NULL
,	NULL
E.	NULL
,	NULL
Nathan	NULL
,	NULL
C.	NULL
&	NULL
Xie	NULL
,	NULL
Q.-W.	NULL
(	NULL
1994	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

180	NULL
,	NULL
977-984	NULL
.	NULL

Xie	NULL
,	NULL
Q.-W.	NULL
&	NULL
Nathan	NULL
,	NULL
C.	NULL
(	NULL
1994	NULL
)	NULL
J.	NULL
Leukocyte	NULL
Biol	NULL
.	NULL

56	NULL
,	NULL
576-582	NULL
.	NULL

DeVera	NULL
,	NULL
M.	NULL
E.	NULL
,	NULL
Shapiro	NULL
,	NULL
R.	NULL
A.	NULL
,	NULL
Nussler	NULL
,	NULL
A.	NULL
K.	NULL
,	NULL
Mudgett	NULL
,	NULL
J.	NULL
S.	NULL
,	NULL
Simmons	NULL
,	NULL
R.	NULL
L.	NULL
,	NULL
Morris	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
Billiar	NULL
,	NULL
T.	NULL
R.	NULL
&	NULL
Geller	NULL
,	NULL
D.	NULL
A	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
93	NULL
,	NULL
1054-1059	NULL
.	NULL

Park	NULL
,	NULL
S.	NULL
K.	NULL
,	NULL
Lin	NULL
,	NULL
H.	NULL
L.	NULL
&	NULL
Murphy	NULL
,	NULL
S.	NULL
(	NULL
1994	NULL
)	NULL
Biochem	NULL
.	NULL

Biophys	NULL
.	NULL

Res	NULL
.	NULL

Comm	NULL
.	NULL

201	NULL
,	NULL
762-768	NULL
.	NULL

Peng	NULL
,	NULL
H.	NULL
B.	NULL
,	NULL
Libby	NULL
,	NULL
P.	NULL
&	NULL
Liao	NULL
,	NULL
J.	NULL
K.	NULL
(	NULL
1995	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270	NULL
,	NULL
14214-14219	NULL
.	NULL

Colasanti	NULL
,	NULL
M.	NULL
,	NULL
Persichini	NULL
,	NULL
T.	NULL
,	NULL
Menegazzi	NULL
,	NULL
M.	NULL
,	NULL
Mariotto	NULL
,	NULL
S.	NULL
,	NULL
Gior-dano	NULL
,	NULL
E.	NULL
,	NULL
Caldarera	NULL
,	NULL
C.	NULL
M.	NULL
,	NULL
Sogos	NULL
,	NULL
V.	NULL
,	NULL
Lauro	NULL
,	NULL
G.	NULL
M.	NULL
&	NULL
Suzuki	NULL
,	NULL
H.	NULL
(	NULL
1995	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270	NULL
,	NULL
26731-26733	NULL
.	NULL

Dawson	NULL
,	NULL
V.	NULL
L.	NULL
,	NULL
Brahmbhatt	NULL
,	NULL
H.	NULL
P.	NULL
,	NULL
Mong	NULL
,	NULL
J	NULL
.	NULL

A	NULL
.	NULL

&	NULL
Dawson	NULL
,	NULL
T.	NULL
M.	NULL
(	NULL
1994	NULL
)	NULL
Neuropharmacology	NULL
33	NULL
,	NULL
1425-1430	NULL
.	NULL

Huang	NULL
,	NULL
P.	NULL
L.	NULL
,	NULL
Dawson	NULL
,	NULL
T.	NULL
M.	NULL
,	NULL
Bredt	NULL
,	NULL
D.	NULL
S.	NULL
,	NULL
Snyder	NULL
,	NULL
S.	NULL
H.	NULL
&	NULL
Fishman	NULL
,	NULL
M.	NULL
C.	NULL
(	NULL
1993	NULL
)	NULL
Cell	NULL
75	NULL
,	NULL
1273-1286	NULL
.	NULL

Chomezynski	NULL
,	NULL
P.	NULL
&	NULL
Sacchi	NULL
,	NULL
N.	NULL
(	NULL
1987	NULL
)	NULL
Anal	NULL
.	NULL

Biochem	NULL
.	NULL

162	NULL
,	NULL
156-159	NULL
.	NULL

Sambrook	NULL
,	NULL
J.	NULL
,	NULL
Fritsch	NULL
,	NULL
E.	NULL
F.	NULL
&	NULL
Maniatis	NULL
,	NULL
T.	NULL
(	NULL
1989	NULL
)	NULL
Molecular	NULL
Cloning	NULL
:	NULL
A	NULL
Laboratory	NULL
Manual	NULL
(	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
Lab	NULL
.	NULL

Press	NULL
,	NULL
Plainview	NULL
,	NULL
NY	NULL
)	NULL
,	NULL
2nd	NULL
Ed	NULL
.	NULL

,	NULL
pp	NULL
.	NULL

7.46-7.48	NULL
.	NULL

Schreck	NULL
,	NULL
R.	NULL
,	NULL
Meier	NULL
,	NULL
B.	NULL
,	NULL
Mannel	NULL
,	NULL
D.	NULL
N.	NULL
,	NULL
Droge	NULL
,	NULL
W.	NULL
&	NULL
Bacuerle	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

175	NULL
,	NULL
1181-1194	NULL
.	NULL

Sarte	NULL
,	NULL
B.	NULL
,	NULL
Stanford	NULL
,	NULL
J.	NULL
,	NULL
LaPrice	NULL
,	NULL
W.	NULL
J.	NULL
,	NULL
Uhrich	NULL
,	NULL
D.	NULL
L.	NULL
,	NULL
Lockhart	NULL
,	NULL
T.	NULL
E.	NULL
,	NULL
Gelerinter	NULL
,	NULL
E.	NULL
&	NULL
Duffy	NULL
,	NULL
N.	NULL
V.	NULL
(	NULL
1978	NULL
)	NULL
Inorg	NULL
.	NULL

Chem	NULL
.	NULL

17	NULL
,	NULL
3361-3365	NULL
.	NULL

Mikoian	NULL
,	NULL
V.	NULL
D.	NULL
,	NULL
Kubrina	NULL
,	NULL
L.	NULL
N.	NULL
&	NULL
Vanin	NULL
,	NULL
A.	NULL
F.	NULL
(	NULL
1994	NULL
)	NULL
Biofizike	NULL
39	NULL
,	NULL
915-918	NULL
(	NULL
Abstr	NULL
.	NULL

English	NULL
)	NULL
.	NULL

Reiling	NULL
,	NULL
N.	NULL
,	NULL
Kroncke	NULL
,	NULL
R.	NULL
,	NULL
Ulmer	NULL
,	NULL
A.	NULL
J.	NULL
,	NULL
Gerdes	NULL
,	NULL
J.	NULL
,	NULL
Flad	NULL
,	NULL
H.-D.	NULL
&	NULL
Hauschildt	NULL
,	NULL
S.	NULL
(	NULL
1996	NULL
)	NULL
Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

26	NULL
,	NULL
511-516	NULL
.	NULL

Murphy	NULL
,	NULL
S.	NULL
,	NULL
Simmons	NULL
,	NULL
M.	NULL
L.	NULL
,	NULL
Agullo	NULL
,	NULL
L.	NULL
,	NULL
Garci	NULL
,	NULL
A.	NULL
,	NULL
Feinstein	NULL
,	NULL
D.	NULL
L.	NULL
,	NULL
Galea	NULL
,	NULL
E.	NULL
,	NULL
Reis	NULL
,	NULL
D.	NULL
J.	NULL
,	NULL
Minc-Golomb	NULL
,	NULL
D.	NULL
&	NULL
Schwartz	NULL
,	NULL
J.	NULL
P.	NULL
(	NULL
1993	NULL
)	NULL
Trends	NULL
Neurosci	NULL
.	NULL

16	NULL
,	NULL
323-328	NULL
.	NULL

Thompson	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
Phillips	NULL
,	NULL
R.J.	NULL
,	NULL
Erdjument-Bromage	NULL
,	NULL
H.	NULL
,	NULL
Tempst	NULL
,	NULL
P.	NULL
&	NULL
Ghosh	NULL
,	NULL
S.	NULL
(	NULL
1995	NULL
)	NULL
Cell	NULL
80	NULL
,	NULL
573-582	NULL
.	NULL

Henkel	NULL
,	NULL
T.	NULL
,	NULL
Machleidt	NULL
,	NULL
T.	NULL
,	NULL
Alkalay	NULL
,	NULL
I.	NULL
,	NULL
Kronke	NULL
,	NULL
M.	NULL
,	NULL
Ben-Neriah	NULL
,	NULL
Y	NULL
.	NULL

&	NULL
Bacuerle	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Nature	NULL
(	NULL
London	NULL
)	NULL
365	NULL
,	NULL
182-185	NULL
.	NULL

Thanos	NULL
,	NULL
D.	NULL
&	NULL
Maniatis	NULL
,	NULL
T.	NULL
(	NULL
1995	NULL
)	NULL
Cell	NULL
80	NULL
,	NULL
529-532	NULL
.	NULL

Matthews	NULL
,	NULL
J.	NULL
R.	NULL
,	NULL
Botting	NULL
,	NULL
C.	NULL
H.	NULL
,	NULL
Panico	NULL
,	NULL
M.	NULL
,	NULL
Morris	NULL
,	NULL
H.	NULL
R.	NULL
&	NULL
Hay	NULL
,	NULL
R.	NULL
T.	NULL
(	NULL
1996	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

24	NULL
,	NULL
2236-2242	NULL
.	NULL

Dawson	NULL
,	NULL
T.	NULL
M.	NULL
&	NULL
Snyder	NULL
,	NULL
S.	NULL
H.	NULL
(	NULL
1994	NULL
)	NULL
J.	NULL
Newrosci	NULL
.	NULL

14	NULL
,	NULL
5147-5159	NULL
.	NULL

Lenardo	NULL
,	NULL
M.	NULL
J	NULL
.	NULL

&	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1989	NULL
)	NULL
Cell	NULL
58	NULL
,	NULL
227-229	NULL
.	NULL

Bo	NULL
,	NULL
L.	NULL
,	NULL
Dawson	NULL
,	NULL
T.	NULL
M.	NULL
,	NULL
Wesselingh	NULL
,	NULL
S.	NULL
,	NULL
Mork	NULL
,	NULL
S.	NULL
,	NULL
Choi	NULL
,	NULL
S.	NULL
,	NULL
Kong	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
Pardo	NULL
,	NULL
C.	NULL
,	NULL
Hanley	NULL
,	NULL
D.	NULL
&	NULL
Trapp	NULL
,	NULL
B.	NULL
D.	NULL
(	NULL
1994	NULL
)	NULL
Ann	NULL
.	NULL

Neurol	NULL
.	NULL

36	NULL
,	NULL
778-786	NULL
.	NULL

Adamson	NULL
,	NULL
D.C.	NULL
,	NULL
Wildemann	NULL
,	NULL
B.	NULL
,	NULL
Sasaki	NULL
,	NULL
M.	NULL
,	NULL
Glass	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
McArthur	NULL
,	NULL
J.	NULL
C.	NULL
,	NULL
Christov	NULL
,	NULL
V.	NULL
I.	NULL
,	NULL
Dawson	NULL
,	NULL
T.	NULL
M.	NULL
&	NULL
Dawson	NULL
,	NULL
V.	NULL
L.	NULL
(	NULL
1996	NULL
)	NULL
Science	NULL
274	NULL
,	NULL
1917-1921	NULL
.	NULL

